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ABSTRACT 
Post Translational Regulation of AID Targeting to both Strands of a Transcribed DNA 
Substrate 
 
Celia D. Keim 
 
 Activation induced Cytidine Deaminase (AID) contributes to the generation of antibody 
affinity by participating in two reactions, class switch recombination (CSR) and somatic 
hypermutation (SHM).  Both reactions occur after VDJ recombination, subsequent to antigen 
exposure.  During CSR, a deletion and recombination event occur to alter the effector function 
from IgM to either IgG, IgE, or IgA.  SHM then occurs, which introduces point mutations at a 
high frequency into the variable regions of both the immunoglobulin heavy and light chains.  
These point mutations increase the antibody binding affinity for antigen, and antibodies with 
greatest affinity for antigen will be positively selected and further expanded during an immune 
response.  
 The ability of AID to act as a mutator gene underscores the importance of understanding 
its regulation throughout the genome.  Action of AID on genes outside of the Ig loci can lead to 
genomic instability.  Hyperactivity of AID has been shown to cause chromosomal translocations 
and other oncogenic malignancies.  Loss of AID can lead to immunodeficiencies.  Therefore, it is 
imperative to understand how AID identifies and interacts with target sequences and mutates 
both strands of the DNA.  Previous studies have identified DNA secondary structure such as R 
loops, transcription factors, miRNA, and phosphorylation as events important for determining 
AID’s   ability   to   access   its   substrate   sequences.   However,   none   of   these   studies   demonstrated  
how AID mutates both strands of DNA, reminiscent to its in vivo mode of action.    
 The focus of this thesis is to identify how AID mutates both strands of the DNA duplex, 
and how its target genes are identified. To this end, we have discovered that AID functionally 
interacts with the cellular non-coding RNA degradation complex, RNA exosome.  We observe 
that the RNA exosome stimulates AID activity on both strands of DNA in in vitro reconstituted 
reactions.  The RNA exosome/AID complex binds to switch (S) sequences in a manner that is 
both transcription- and AID-dependent. Knockdown of exosome core component ExoSc3 results 
in defects in CSR. 
  Additionally, this work focuses on the role of the neddylation (Nedd8) of AID in 
recruitment to its target sequences.  Neddylation, a 10kDa modifier, is a small ubiquitin like 
modifier which functions in a variety of cellular processes. We have used a combination of 
proteomics, computational approaches, and candidate screening to identify and validate the role 
of E1, E2 and E3 in CSR. We have identified NEDD4 as the AID-specific E3 Neddylation ligase 
and demonstrated its requirement for CSR in mouse B cells. Using mass spectrometry, we have 
identified AID neddylation sites from in vitro neddylated AID proteins.  We observe that 
mutation of these AID-neddylation sites affects AID/RNA exosome interaction and CSR 
efficiency in B cells. These observations point towards a role of NEDD4 in recruiting AID/RNA 
exosome complex to the immunoglobulin locus. Additionally, we confirm the role of NEDD4 as 
an E3 ubiquitin ligase of RNA polymerase.  In both cell lines and primary cells, we observe an 
increase of germline transcripts and S region resident RNA polymerase in the absence of 
NEDD4. We propose NEDD4 ubiquitination can promote the degradation of stalled RNA 
polymerase complexes at the Ig S region, facilitating exosome access to germline transcripts and 
AID access to the template strand.  
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1. Chapter 1: Literature Review 
1.1. Development of the Vertebrate Immune System 
1.1.1. Innate immune system of Invertebrates and Plants 
 The role of the immune system is to protect the organism from infection. The innate 
immune system is the first line of defense against an invading pathogen. Innate immunity is 
present in all organisms at all times and does not increase following repeated exposures.  The 
innate immune system is comprised of germ-line encoded receptors which recognize highly 
conserved pathogen associated molecular patterns (PAMPs).  These receptors are known as 
pattern recognition receptors (PRRs) (Pancer and Cooper, 2006).  Analysis of the genomes of 
various organisms reveals a limited number of PRRs to detect invading pathogens.  In plants, it 
has been hypothesized that rather than each PRR recognizing a single pathogen, detection may 
occur indirectly via pathogen-derived virulence proteins which are delivered into the cell wall to 
trigger host resistance (Jones and Takemoto, 2004).   
 
1.2. Key Activator Pathway of Innate Immunity -Toll Pathway 
 Identification of key pathways in the innate immune system was discovered in the model 
organism Drosophila. The immune system of Drosophila composes both cellular and humoral 
reactions.  Exposure to pathogens induces expression of antimicrobial peptides, which block 
growth of pathogens in the haemolymph. Identification of the promoter regions of the 
antimicrobial peptide genes revealed nucleotide motifs similar to mammalian binding sites for 
NF-κB/Rel   proteins.   Previous studies had revealed Drosophila expresses a NF-κB   family  
protein, Dorsal, which functions in regulation of dorsoventral patterning(Nusslein-Volhard et al., 
1980). Release of Dorsal from its inhibitor is dependent on activation of the transmembrane Toll 
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receptor, a cytokine-like protein (Hoffmann, 2003). Loss of function mutations of Toll resulted 
in immunocompromised flies (Hoffmann, 2003). It was discovered that mammalian genomes 
also encoded a family of Toll-like receptors (TLRs) (Rock et al., 1998).  In both flies and 
mammals, infection and recognition by a TLR leads to activation of NF-κB  family  members  and  
expression of immune response genes (Hoffmann, 2003). However, only one of eight Toll 
homologues in the Drosophila genome functions in host defense, whereas the vertebrate 
homologues of Toll function exclusively in immunity (Pasare and Medzhitov, 2004).  
 Vertebrates contain approximately 12 TLR genes, with the exception of fish which retain 
duplicate genome copies and therefore more TLR genes (Pancer and Cooper, 2006). In addition, 
soluble TLR forms exist which may also participate in immunity.  For example, a duplicate copy 
of the TLR5 gene in fish and amphibians produces soluble TLR5 in the liver following bacterial 
infection (Tsujita et al., 2004). Additionally, in chicken, alternative splicing of TLR3 and TLR5 
yields soluble TLR forms (Yilmaz et al., 2005) 
 
1.3. Adaptive Immune system  
 A further extension of the immune system with the additional property of memory, the 
adaptive immune system, evolved in the ancestors of jawless fish.  The adaptive immune system 
is mediated by lymphocytes, which are specialized cells that contain movable gene segments, or 
immunoglobulin (Ig) genes.  The Ig gene segments, V, D, and J, can be rearranged in 
approximately 3.5 x 106 possible combinations to recognize the antigenic component of a 
pathogen (See Figure 1-3 for details on VDJ rearrangement). In invertebrates, evidence of a role 
of Ig-like domains in pathogen recognition and self/non-self discrimination was reported in the 
protein hemolin, a plasma protein from lepidopteran insects. Hemolin was demonstrated to bind 
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to the surfaces of bacteria and yeast, as well as lipopolysaccharide (LPS) secreted from Gram-
negative bacteria and lipoteichoic acid from Gram-positive bacteria (Yu and Kanost, 2002).  In 
Drosophila, alternative splicing of the Ig-superfamily receptor Downs Syndrome adhesion 
molecule (DSCAM) results in expression of potentially over 18,000 different isoforms. This 
splicing mechanism generates molecular diversity within immune competent cells and is 
conserved across major insect orders (Watson et al., 2005). Although both hemolin and DSCAM 
isoforms utilize Ig-like molecules, these recognition motifs utilize neither recombination 
mechanisms nor lymphocytes, therefore remaining a component of innate immunity.  
 Two different strategies for recombinatorial lymphocyte antigen receptor diversification 
arose at the time of vertebrate evolution, around 500 million years ago(Pancer and Cooper, 
2006).  Agnathans (jawless fish), composed of the two species lamprey and hagfish, assemble 
lymphocyte receptor genes through a recombination process which utilizes variable lymphocyte 
receptors (VLRs) tethered to the cell surface via an invariant glycosyl-phosphatidyl-inositol 
anchor (Pancer et al., 2004). The VLR contains diverse leucine rich repeats (LRRs) within 
flanking amino and carboxy terminal LRRs.  Rearrangement of the VLR occurs by insertion of 
the LRR cassettes into an incomplete germline VLR gene to result in a unique VLR gene. 
Examination of purified erythrocyte and lymphocyte populations reveals mature VLR amplicons 
only in lymphocytes, suggesting that mature VLRs are generated through a somatic DNA 
rearrangement process in lymphocytes (Pancer et al., 2004). The rearrangement system in 
gnathostomes (jawed vertebrates) is similar; however, the Ig domain replaces the LRR domain as 




Figure 1-1: Structure of Vertebrate Ig Molecule: Adapted from Tonegawa, 1983. (Tonegawa, 
1983)The Ig molecule is comprised of two identical light chains (blue) and two identical heavy chains 
(orange) connected by disulfide bonds (yellow), each containing an amino terminal variable (VL or VH) 
region and carboxy-terminal C region (CL or CH).  
 
 Generation of the primary repertoire occurs in pre-B cells through the process of V(D)J 
recombination, in which different immunoglobulin V, D, and J gene segments are chosen to 
encode a functional antigen receptor (Tonegawa, 1983). There are multiple copies of each V, D, 
and  J  segment.  For  example,  in  the  human  κ  light  chain,  there  are  approximately  40  Vκ  segments  
and  5  Jκ  which  can  be  recombined   in  200  combinations.   In   the  human  λ   light  chain,   there  are  
approximately   30   Vλ   segments   and   4   Jλ   which   can   be   recombined   in   120   combinations.  
Therefore, there can be 320 possible unique light chain combinations.  In the human heavy chain 
locus, there are 65 VH segments, 27DH segments, and 6JH segments, yielding 65 x 27 x 6, or 
11,000 possible combinations. One heavy chain region and one light chain region is combined to 
produce a functional B cell, yielding 320 x 11,000 or 3.5 x 106 possible combinations (Charles A 
Janeway, 2007). 
 Recombination signal sequences (RSS), highly conserved sequences separated by 12-mer 
(12-RSS) or 23-mer spacers (23-RSS), flank each V, D, and J segment (Tonegawa, 1983).  The 
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RSS direct the reaction as recombination can only occur between a 12-RSS and a 23-RSS.   The 
process next occurs in two steps, a cleavage reaction followed by a joining reaction.   The 
cleavage reaction is mediated by the recombination activation genes, RAG1 and RAG2, which 
function together as an endonuclease (Oettinger et al., 1990) along with HMG1 or 2, to form the 
RAG complex.  In vivo, RAG binding is targeted to a region of active chromatin of the J 
segments  in  the  Igκ  and  Tcrα  loci,  and  J  and  J-proximal D gene segments in the IgH and  Tcrβ  
loci. Promoters  and  enhancers  direct  the  targeted  binding  of  RAG1  at  Jα  and  Dβ/Jβ  segments (Ji 
et al., 2010a), whereas RAG2 binding is broadly distributed at sites containing histone 3 
trimethylated at lysine 4 (Ji et al., 2010b). Assembly of the RAG complex is tightly regulated 
and is in a lineage and developmental stage specific manner (Ji et al., 2010b). This complex 
introduces double strand breaks between the recombining gene elements and their RSS via a 
transesterification   reaction  which   utilizes   the   3’hydroxyl   on   each  V,   D,   or   J   coding   end   as   a  
nucleophile (van Gent et al., 1996).  This cleavage creates two blunt-end,   5’   phosphorylated  
signal ends and two hairpin-sealed coding ends (Figure 1-3).  
In the next step, the coding ends must be processed, and the blunt signal ends must be 
joined by the non homologous end joining pathway (NHEJ) (Lieber, 1999). Artemis protein then 
opens the hairpins (Ma et al., 2002),  leaving  3’  overhangs  which  are  extended  by  nontemplated  
nucleotide addition by TdT (Tsai et al., 2007).      This   3’   extension   also   creates   additional  
immunoglobulin  diversity.    However,  the  sequence  of  the  3’  overhang  must  be  preserved  during  
non-homologous end-joining activity because DNA polymerases will require a primer in order to 
replicate  DNA  in   the  5’ to 3’  direction.     To  solve   this  problem,   the  proteins  Ku,  XRCC2, and 
Cernunnos   ligate   the   3’   overhanging   hydroxyl   group   to   the   5’   phosphate   of   the   opposing   end  
(Tsai et al., 2007).  
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Inherited mutations in RAG1 or RAG2 result in defective recombinase activity, leading to 
syndromes of severe combined immunodeficiencies, the most common types being Omenn 
Syndrome and T-and-B-cell severe combined immunodeficiency (T-B-SCID) (Corneo et al., 
2001).  Rag1 -/- and Rag2 -/- mice display an inability to initiate V(D)J recombination, and  
absence of B and T cells consistent with a SCID phenotype (Mombaerts et al., 1992; Shinkai et 
al., 1992). Analysis of human patients displaying SCID phenotype (B cell negative) revealed 
missense, nonsense, and deletion mutations in either Rag1, Rag2, or both genes with the 
functional effect of defective recombinase activity (Schwarz et al., 1996). A case study of 
patients with inherited mutations in either Rag1 or Rag2 genes were the genetic component of 
the phenotypically characterized Omenn syndrome (Corneo et al., 2001). This disease is 
characterized by eosinophilia, an absence of circulating B cells, and an infiltration of oligoclonal 
T cells with a skewed Th2 phenotype to the skin and intestine (Omenn, 1965). However, SCID 
patient genotype analysis reveals the same mutations may result in different clinical outcomes in 
different patients, suggesting environmental or epigenetic factors may play a role in disease 




Figure 1-2: Overview of VDJ recombination: V(D)J recombination leads to diversity in 
immunoglobulins.  Each V, D, and J segment is present in multiple copies, each of which is capable of 
recombination into a functional variable (IgV) region. The RAG complex binds at the recombination 
signal sequence (RSS, indicated on figure) to mediate cleavage and joining at recombining gene elements. 
A single functional V, D, and J gene segment is recombined to form a functional coding unit.  After 
V(D)J recombination, all B cells express antibody isotype IgM or IgD until further antibody 






Figure 1-3: Mechanism of V(D)J Recombination: Adapted from Weaver et al, 1995 (Weaver et al., 
1995). 1. Cleavage: Cleavage by the RAG1/RAG2 recombinases occurs at the border of each 
recombination  signal  sequence  (RSS,   triangles).  RSS  are  5’phosphorylated  and  blunt  ended.  2.  
Joining: a: Coding junction formation at the hairpin end DNA is nicked, leading to a variety of  
end structures which are processed by the non-homologous end joining pathway. B. Coding 
junction formation at the blunt end: RSS joints are usually precise.  
 
1.3.1. Evolution in vertebrates 
 The evidence of lymphocytes in agnathans suggests that lymphocytes evolved in the 
common ancestor of the vertebrates (Pancer and Cooper, 2006). Evidence from the last common 
ancestor of plants and metazoans suggests that a version of LRR containing protein was utilized 
for microbial detection (Meyerowitz, 2002). It is unknown at what time during evolution 
lymphocytes have appeared and an invertebrate homologue of the lymphocyte has yet to be 
characterized (Pancer and Cooper, 2006).  As vertebrates rapidly evolved, a rate limiting step in 
evolution may have been to develop LRR containing proteins to the expanding number of 
potential pathogens.  Additionally, self-reactivity may have posed a problem as the number 
evolved.  These factors may have required vertebrates to shift to the strategy of recombinatorial 
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Ig receptors, where the immune system proteins could be adjusted as the number of potential 
antigens increased (Pancer and Cooper, 2006).  
 As the scheme evolved in vertebrates, it is clear that both branches of the immune system 
retained overlap.  B lymphocytes express TLRs. TLR ligation on B cells induces proliferation, 
expression of co-stimulatory molecules, and leads to plasma cell differentiation (Pasare and 
Medzhitov, 2004). TLR signaling can contribute to T cell signaling by leading to the secretion of 
cytokines (Pasare and Medzhitov, 2004).  Furthermore, in patients with genetic defects in T or B 
cell production, severe combined immunodeficiencies result, leading to viral and bacterial 
infections, illustrating the importance of both arms of the immune system (Rosen et al., 1984). 
 
1.3.2. Cellular Components of the Immune System 
 The adaptive immune response consists of two types of antigen responsive cells, B and T 
cells. They secrete antibodies and lymphokines, respectively, to recruit additional cells including 
macrophages, neutrophils, mast cells, basophils, eosinophils, and natural killer cells which 
participate in the immune response. All cells of the immune system are derived from a common 
precursor cell, the pluripotent hematopoietic stem cell in the bone marrow. See Figures 1-4 and 
1-5 for cellular and lineage progression.  However, C. elegans has not been demonstrated to 
display cellular immune defenses but may instead utilize an enzymatic defense system (Millet 
and Ewbank, 2004).   
 The myeloid progenitor cell is the precursor of the granulocytes, macrophages, dendritic 
cells, and mast cells (Bottero et al., 2006). Granulocytes are produced during the innate immune 
response and travel to the site of infection.  Granulocytes include neutrophils (a phagocytic cell), 
eosinophils (a defense against parasitic infections), and basophils (function unknown). 
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Macrophages are a phagocytic cell with a critical role in innate immunity.  Mast cells, when 
activated, are believed to play a role in protection from pathogens.  Dendritic cells are 




Figure 1-4: The Generation of Cellular Components of the Immune system Adapted from Janeway et 
al, Immunobiology (Charles A Janeway, 2007). The pluripotent hematopoietic stem cell in the 
bone marrow gives rise to all the cellular elements of the immune system. A distinguishing 
feature of T and B cells is the site of differentiation.   Colors indicate physiological location: 
blue, bone marrow; orange, thymus; red, blood; green, tissues, including peripheral lymphoid 
tissues.  
 
 The common lymphoid progenitor cell is the precursor of the B and T lymphocytes, 
which are the key antigen responsive cells of the adaptive immune response.  Antigen is 
recognized through the B cell receptor (BCR), located on the membrane surface of B cells.  B 
cells are capable of recognizing soluble antigen as well as antigen on the surface of APCs, 
including dendritic cells (Huang et al., 2005b), follicular dendritic cells (Chen et al., 1978), and 






























macrophages (Koppel et al., 2005). However, membrane bound antigen seems to be more 
effective at inducing activation than soluble antigen because a greater amount of soluble antigen 
is required to induce a response (Batista and Neuberger, 1998).  
 
Figure 1-5: Hematopoietic Differentiation, adapted from Bottero et al, 2006 (Bottero et al., 2006). The 
pluripotent hematopoietic stem cell in the bone marrow gives rise to all the cells of the immune system.  
Lineage differentiation of B cells and T cells is indicated, with mature cell type as far left boxes.  
 
 The BCR consists of an antigen binding membrane immunoglobulin domain (mIg) in 
complex with immunoreceptor tyrosine kinase motifs (ITAMs) which facilitate intracellular 
signal transmission (Reth, 1989).  When bound by antigen, the BCR crosslinks and 
phosphorylation of the ITAMs occurs by the Src family kinase Lyn, which initiates the formation 
of the signalosome complex. The signalosome initiates downstream events to internalize and 
process antigen, after which it is loaded onto the major histocompatibility complex (MHC) and 
presented by the B cell (DeFranco, 1997; Rock et al., 1984).  Antigen presentation allows for 
recruitment of CD4+ helper T cells, which will facilitate completion of the B cell activation 

































 The probability of interaction with antibody is increased by B cell residence in locations 
of peripheral lymphoid tissues, which   include   the   spleen,   lymph   nodes,   Peyer’s   Patches,   and  
tonsils (see Figure 1-6).  These sites contain areas known as T-cell rich areas, or T-zones, due to 
their upregulation of specific chemokine receptors in response to antigen loaded DCs (Klein and 
Dalla-Favera, 2008). It is here at the T-zone where naïve B cells become fully activated by CD4+ 
helper T cells (Th cells) and become mature activated B cells. The interaction of TNF receptor 
family member CD40, constitutively expressed on B cells with its receptor CD40L (gp39), 
expressed on activated Th cells is required for formation of GCs.  Th cells secrete additional 
cytokines which function to stimulate B cell proliferation and differentiation through the process 




Figure 1-6: Sites of Lymphoid Tissues are Located Throughout the Body: Adapted from 
Janeway et al, 2007(Charles A Janeway, 2007).  Lymphocytes arise in the bone marrow. B 
lymphocytes mature in the bone marrow, while T lymphocytes migrate to the thymus to 
complete maturation.  Lymphocytes then migrate to the peripheral (secondary) lymphoid organs 
where they are activated by antigen encounter. Peripheral lymphoid organs, as indicated, include 
the   lymph   nodes   and   mucosal   associated   tissues   such   as   gut,   tonsils,   Peyer’s   patches, and 
appendix. Lymphatics drain lymph fluid containing the lymphocytes from the peripheral 
lymphoid tissues into the thoracic duct which empties into the subclavian vein. The lymph 






1.3.3 Germinal Center (GC) Events 
 When activated, the germinal center (GC) response is initiated, during which a B cell will 
differentiate into either a plasma cell which undergoes clonal expansion and secretes antibodies, 
or a memory cell with long lived memory to the antigen (Harwood and Batista, 2010).  The GCs 
are the main site where somatic hypermutation (SHM) occurs in the Ig variable region genes, an 
essential process in the generation of high affinity antibodies (Jacob et al., 1991). The activated 
B cells either immediately begin secreting low affinity antibodies at extrafollicular sites of 
plasmablast growth and differentiation, or move into the primary follicle. The primary follicle is 
a structure composed of recirculating IgM+IgD+ B cells, within a network of follicular dendritic 
cells carrying antigen on their surface and are critical for optimal selection of B cells (Klein and 
Dalla-Favera, 2008).  These proliferating B cells form a mantle zone around the GC to form the 
secondary follicle, and after several days, the structure of the GC can be observed, as in Figure 




Figure 1-7: Germinal Center B Cell Events: Adapted from Klein and Dalla-Favera, 2008. (Klein and 
Dalla-Favera, 2008) Activated B cells enter the germinal center (GC) and undergo proliferation and 
clonal expansion within the dark zone of the GC, becoming centroblasts. Also in the dark zone the 
centroblasts undergo the process of somatic hypermutation (SHM) to alter affinity within the IgV region.  
GC centroblasts then differentiate into centrocytes and move into the light zone where they are presented 
with antigen by follicular dendritic cells and T cells. Here they are selected for binding to the antigen. A 
subset of centrocytes undergo class switch recombination (CSR) which alters the effector function. 
Centrocytes selected for antigen eventually differentiate into plasma or memory B cells, and those 
negatively selected undergo apoptosis.   
 
 
 To achieve high amounts of high affinity immunoglobulin during an immune response, 
centroblasts display high proliferation rates.  Rates for cell cycle completion range from 6 to 12 
hours (MacLennan, 1994). Correspondingly, increased transcription of  cell cycle regulators and 
pro-apoptotic factors have been found in centroblasts, while negative regulators of cell cycle and 
anti-apoptotic factors are downregulated (Klein et al., 2003).  Additionally, the enzyme 
telomerase is expressed to maintain integrity of replicated DNA ends during rapid proliferation 
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(Hu et al., 1997).  Upon final differentiation to memory or plasma B cells, gene expression 
returns to a profile similar to that of naïve B cells, except pro-and anti-apoptotic genes are both 
expressed to prepare for death and survival, as well as changes in expression of cell surface 
receptors (Klein et al., 2003).  
   
1.3.4. Somatic Hypermutation  
1.3.4.1. Definition and Location 
 Within the dark zone of the GC, centroblasts undergo the process of somatic 
hypermutation (SHM) in which modifications are made in the rearranged V(D)J regions to 
increase antibody affinity towards antigen.  In this process, C is deaminated to U in and around 
the rearranged V region Ig genes in a reaction initiated by Activation Induced Deaminase (AID) 
(Petersen-Mahrt et al., 2002; Rada et al., 2002b). (See Section 1.4 for an extensive discussion of 
AID.) 
 
1.3.4.2. Mechanism of DNA Deamination  
 SHM is proposed to occur in a two phase deamination mechanism, initiated by the action 
of AID (Figure 1-8). In Phase 1, AID initiates mutations by specific deamination of 
deoxycitidines to deoxyuridines (Neuberger et al., 2005). At Sμ and most Sγ sequences, the 
switch associated mutation domains initiate around 150nt downstream of the exon 1 start sites 
and extend over several kb through the S region (Xue et al., 2006). Sequence hotspots for 
mutation in the V regions occur primarily within DNA sequence motifs RGYW/WRCY (where 
R=A/G, Y=C/T, W=A/T and the hotspot G:C is bold). Further analysis examining the mutability 
of the RGYW motif revealed that CGYW/WRCG is mutable in vitro but not in vivo. This 
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discrepancy may due to the presence of a CG dinucleotide repeat characteristic of CpG islands, 
and when mutated in vivo, may be repaired by DNA repair enzymes (Rogozin and Diaz, 2004). 
Therefore, a modification on AID-driven SHM hotspot motif is proposed as DGYW/WRCH 
(D=A,G,T; Y=C,T; W=A,T) (Rogozin and Diaz, 2004). As more than half of the cytosines on a 
nontemplate DNA strand conform to this motif, studies using cell line based CSR assays have 
demonstrated that it is not the direct sequence which is critical for CSR but the overlapping AID 
hotspot motif on the two DNA strands which is important.  These studies have found the 
densities of these regions correlate with CSR efficiency and the quality of the switch region (Han 
et al., 2011). At the DNA level, length of microhomologies decrease in length from AGCT > 
TGCT > GACT, with break points scattered and not associated with any particular motif (Han et 
al., 2011). 
 
1.3.4.3. Mechanism of Lesion Repair 
 Faithful replication of the U-G mispair generated in Phase I results in a transition 
mutation at C-G pairs, where the U residue is processed as a T. Therefore, after replication, the 
resulting daughter cells will contain a U-A pair, which will be later propagated as a T-A pair. A 
transition mutation results because later generations will have a C-to-T or G-to-A transition due 
to the T-A pair in place of the original C-G pair (Neuberger et al., 2005). The second possibility 
for repair leads to transversion and transition mutations, in which the aberrant dU residues are 
detected by uracil DNA glycosylase (UNG) and processed by the base excision repair pathway 
(Rada et al., 2002b). Transversion mutations are created when the original C-G pair is replaced 
with an A-T or G-C pair.  This replacement could occur because an abasic site is a type of non-
instructional lesion, where the polymerase can incorporate any base into the site. Replication past 
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the site requires a normal replication polymerase or a trans-lesion polymerase (Neuberger et al., 
2005).  
 Phase 2 mutation occurs when the dU/dG lesion is recognized by the Msh2/Msh6 
heterodimer and subsequently processed by the mismatch repair pathway, leading to mismatches 
mainly restricted to A-T pairs (Neuberger et al., 2005; Phung et al., 1998; Wiesendanger et al., 
2000).  Aberrant repair  due   to   low  fidelity  polymerase  η   (Rogozin et al., 2001) action at these 
sites creates a characteristic repair pattern, in which A residues are targeted approximately twice 
as often as T residues on the top, non-transcribed (nontemplate) strand (Neuberger et al., 2005). 
Strand-biased spread of mutations in SHM appears to arise from the preferential targeting of 
error-prone mismatch repair pathway to top-strand  U’s  (Unniraman and Schatz, 2007). Although 
AID can access both strands equally, differential repair results due to targeting of mismatch 
repair machinery, but not base excision machinery, to lesions on the top but not bottom strand 
(Unniraman and Schatz, 2007).  As a result of SHM, if the mutated V genes result in high 











 Figure 1-8: Two Step DNA Deamination Model for SHM: Adapted from Neuberger et al, 
2005(Neuberger et al., 2005). Mutation occurs in two phases, which is initiated by the action of activation 
induced cytidine deaminase (AID). AID deaminates C (deoxycytidine) to U (deoxyuridine) in Phase 1.  
This action results in a lesion where U is mispaired with G (deoxyguanosine). Uracil DNA Glycosylase 
(UNG) excises the U, resulting in an abasic site.  Replication over the abasic site yields either transition or 
transversion mutation at C-G pairs. During Phase 2, DNA lesions made in Phase I are recognized, leading 





1.3.5. Class Switch Recombination 
1.3.5.1. Definition and Location 
  Diversity generation is also created in the light zone by switching the immunoglobulin 
constant regions (CH) in a process known as class switch recombination (CSR). The constant 
region of an immunoglobulin determines the class of Ig produced by the B cell.  There are five Ig 
classes determined by the CH region, including IgM, IgD, IgG, IgE, and IgA. These classes 
determine the effector function and antigen response of the antibody.  IgM is the first Ig class 
produced during B cell development, and subsequent antigen exposure induces CSR to 
downstream classes.   
 
1.3.5.2. IgH locus Organization  
 Characterization of the CSR mechanism reveals a deletion and recombination event 
occurs of the CH genes intervening between a variable region exon and a CH gene to be expressed 
(Honjo and Kataoka, 1978). CH gene deletion profiling studies using murine myeloma cells 
designated the CH gene order on the chromosome (Figure 1-9) (Honjo and Kataoka, 1978), 
which was later confirmed using chromosome walking studies: 5’-JH-(6.5 kb)-Cμ-(4.5 kb)-Cδ(55 
kb)-Cγ3-(34kb) -Cγl-(21 kb)-Cγ2b-(15 kb)-Cγ2a-(14 kb)-Cε-(12kb)- Cα-3’(Shimizu et al., 1982). 
 
 
Figure 1-9: Mouse IgH locus Organization: RAG1/RAG2 recombinases mediate productive Ig heavy 





1.3.5.3. Transcription through S regions 
 Recombination occurs at stretches of tandem repeats of short G rich sequences, located 
5’of  each  CH gene (with the exception of Cδ), termed switch (S) regions (Dunnick et al., 1993; 
Kataoka et al., 1980). The tandem repeats of the S regions have repeats unique to each CH 
region; however, these regions frequently contain short motifs such as GAGCT or TGGGG 
(Dunnick et al., 1980; Kataoka et al., 1981). Recombination sites can be located throughout the 
tandem   repeats,   or   at   the   5’end,  middle,   or   3’end  of   the   switch   region   (Dunnick et al., 1993). 
Switch  recombination  initiates  at  the  Sμ  region,  which  can  join  with  any of the other downstream 
S regions in a mechanism that results in looping-out of the intervening DNA between S regions, 
which is later excised as a circular piece of DNA (Iwasato et al., 1990).   
 In analyses of SHM mutations in mouse and human, mutations begin to appear 100-200 
base pairs downstream of the transcription start site, and gradually decline as the distance from 
the promoter increases.  The peak of mutations is observed at 400-500 base pairs after the 
transcription start site, restricting mutation to the variable region and not the constant region 
(Lebecque and Gearhart, 1990; Rada and Milstein, 2001).  However, synthetic duplication of the 
promoter upstream of both the variable region and the constant region resulted in mutations in 
both the variable and constant regions at a similar frequency, linking SHM to transcription 
initiation (Peters and Storb, 1996).  Additionally, deletion of the endogenous germline promoter 
upstream  of  the  Sμ  region  resulted  in  extremely  low  levels  of  CSR,  also  indicating  that  both  the  
presence of an intact promoter region and transcription are required for CSR to occur (Bottaro et 
al., 1994). To investigate the role of the promoter in SHM and CSR, several studies were 
performed in which the endogenous promoter was replaced with a transgene or a heterologous 
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promoter (Bottaro et al., 1994; Tumas-Brundage and Manser, 1997). In these studies, CSR and 
SHM were found to take place with the replacement promoter, indicating that specificity does 
not lie within the promoter. It is possible that the primary role of the promoter is to drive 
transcription, which is necessary for AID targeting to S regions, which is discussed further in 
Section 1.5.1. However, not all heterologous promoters can support CSR and SHM.  
Replacement   of   the   endogenous   promoter   with   chicken   β-actin and human EF-1 resulted in 
higher levels of transcription than were observed with the endogenous IgL promoter, but the EF-
1 promoter did not support efficient SHM (Yang et al., 2006). These experiments suggest that 
additional levels of control may be in place to control transcription and AID binding, including 
transcription factors which bind at the promoter.  The Ig isotype is determined by cytokine 
stimulation, which activates transcription through the promoter (Table 1-1).  
Cytokine  IgM  IgG3  IgG1  IgG2b  IgG2a  IgE  IgA  
IL-4  Inhibit  Inhibit  Induce   Inhibit  Induce   
IL-5        Augment  
IFN-γ  Inhibit  Induce  Inhibit   Induce  Inhibit   
TGF-β  Inhibit  Inhibit   Induce    Induce  
IFN-α    
Inhibit 
(+IFNγ)   Induce  Inhibit  











Table 1-1: Transcriptional Activation of S Regions is Determined by Cytokine Simulation:  Adapted 
from Janeway, 2007 (Charles A Janeway, 2007) and Severinson et al, 1990 (Severinson et al., 1990) . 
Cytokine  stimulation  activates  germline  I  promoters  which  lie  upstream  (5’)  to  each  constant  region  (CX) 
gene. Transcription through the CX region targets AID to the switch (S) regions to mediate class switch 





1.3.5.4. Cell Proliferation and Cell Cycle Control   
 CSR requires proliferation of the cell. Switching to IgG and IgA is not detected until the 
third cell cycle, requiring at least two complete cell cycles, and additional divisions for IgE 
switching (Deenick et al., 1999; Hasbold et al., 1998; Hodgkin et al., 1996).  Downregulation of 
IgM and IgD occurs following cytokine stimulation (Hasbold et al., 1998). Additionally, the 
mode of activation (LPS or anti-CD40) can alter the relationship with division (Deenick et al., 
1999).  Division linked switching is distributed in a Gaussian probability distribution, centered 
around a mean division number.  Furthermore, divisions exist at which switching to IgG2b and 
IgG3 overlap, supporting a model of stochastic and independent switching by which no 
intermediate acceptor sites are utilized (Deenick et al., 1999).  
 The link between division and CSR may be attributed to the requirements of the first step 
in the CSR mechanism, transcriptional activation through the S region (Kinoshita et al., 1998), 
which is required for CSR to occur (Gu et al., 1993).  However, transcription through S regions 
alone is not sufficient to induce CSR; the action of the class switch recombinase AID is required 
to initiate breaks in the DNA at both the donor and acceptor switch regions by deamination of C 
to U (Petersen-Mahrt et al., 2002; Xue et al., 2006).  
1.3.5.5. Mechanism: Conversion of AID Lesion to DSBs 
  The presence of the AID induced dU triggers base excision repair, with dU being 
removed by uracil deglycosylase (UNG). An absence of UNG results in repair of the dU:dG 
lesions by replication, resulting in a dCÆdT transition (and dGÆdA) (Petersen-Mahrt et al., 
2002; Xue et al., 2006). Consequently, AID initiated mutations are enhanced by a deficiency in 
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UNG, supporting the mechanism of AID action on dC. The mutation frequency of AID 
expression in an UNG deficient E. coli strain is greater than the sum of the individual mutation 
frequency of either AID expression or UNG deficiency alone. (Petersen-Mahrt et al., 2002).  
Additionally, if AID were to act on dG rather than dC, endonuclease V, encoded by the nfi locus, 
would be required for removal of deoxyxanthosine (He et al., 2000).  Increased mutation 
frequency was not observed in nfi deficient cells, indicating that AID mediated deamination 
occurs on dC and not dG (Petersen-Mahrt et al., 2002).  
 Following UNG action, an abasic site is left at the site of dU removal.  This site must be 
repaired by the action of the base excision repair (BER) enzyme AP endonuclease (APE), which 
cuts the phosphodiester bond of the DNA at abasic sites, resulting in single stranded breaks 
(Christmann et al., 2003).  There are three homologues of APE in mammals, APE1, APE2, and 
PALF/APLF/XIP1 (Hadi et al., 2002; Iles et al., 2007).  APE1 is considered to be the main AP 
endonuclease, as it is required for embryonic development (Xanthoudakis et al., 1996); however, 
both APE1 and APE2 are required for CSR (Guikema et al., 2007).  Reduced switching to all 
isotypes was observed from splenic B cells isolated from ape1+/-, ape2Y/-, and ape+/-/ape2Y/- (APE 
double deficient) mice. Switch region microhomologies were not altered in these cells, 
suggesting that APE1/APE2 does not function in the processing of S-S junctions. However, upon 
analysis of   Sμ,   it   was   observed   that   DSBs   in   this   region   were   reduced,   suggesting   that  
APE1/APE2 functions at abasic sites to initiate DSBs (Guikema et al., 2007).   
 The deoxyribose  phosphate  group  (dRP)  is  still  attached  to  the  5’  end  at  the  break  after  
AP   action.   The   lyase   activity   of   DNA   polymerase   β   excises   this   group,   generating   the   SSBs  
which are later converted to DSBs (Stavnezer and Schrader, 2006). The proposed mechanism of 
DSB initiation includes enzymes of the mismatch repair pathway (MMR) (Stavnezer and 
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Schrader, 2006). The U:G mismatch is recognized by a heterodimer of Msh2-Msh6 (Wilson et 
al., 2005). The Msh2-Msh6  heterodimer  stimulates  the  action  of  DNA  polymerase  η (Wilson et 
al., 2005), an error prone translesion polymerase which is critical to introduce mutations at A/T 
bases (Faili et al., 2004).  
 After  DSB  formation,  5’  and  3’  single  strand  overhangs  which  remain  must  be  processed  
to create appropriate ends for end joining. The transcribed switch regions are cleaved by the 
nucleotide excision repair proteins XPF-ERCC1 and XPG. XPF-ERCC1 cleaves the 5’R   loop  
duplex junctions in both strands at positions which are a few base pairs into the duplex region. 
The cleavage efficiencies are similar on both the template or non-template strands, suggesting 
that only short single stranded regions are required for XPF-ERCC1 activity (Tian and Alt, 
2000). XPG cleaves the non-template   strand  3’R   loop  duplex   junction,  with  no  activity  on   the  
template strand. This activity suggests that longer single stranded regions may be necessary for 
activity. Upon analysis of transcribed S regions in a physiological orientation, it was determined 
that most cleavage occurs on the non template strand and is mediated by XPF. However, both 
nucleases were found cleave throughout the S regions, but no cleavage was found outside the S 
regions. Also, no cleavage was detected on untranscribed S regions, suggesting XPF-ERCC1 and 
XPF specifically target S regions in a transcription dependent manner (Tian and Alt, 2000).
 Recombination of the donor and acceptor S regions frequently lack homology, suggesting 
homologous recombination is not the mechanism of joining (Dunnick et al., 1993). S regions are 
recombined using proteins of the non homologous end joining pathway (NHEJ) (Ma et al., 2005) 
or the microhomology dependent alternative end joining pathway (Boboila et al., 2010; Pan-
Hammarstrom et al., 2005). Essential NHEJ proteins have been shown to be important for CSR, 
including Ku70, Ku80, and the XRCC4-ligase IV complex (Casellas et al., 1998; Manis et al., 
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1998; Pan-Hammarstrom et al., 2005).  In the absence of XRCC4-ligase IV, CSR has been 
demonstrated to occur largely by a microhomology-mediated alternative end joining pathway 
(Boboila et al., 2010), A-NHEJ. Absence of both XRCC4-ligase IV and Ku70/80 leads to joining 
via the alternative end joining pathway. Additionally, mice heterozygous for Xrcc1 display 
significant increases in SHM frequencies and double strand breaks in S regions during CSR. 
Analysis of the S region junctions revealed a decrease in the length of microhomology, 
suggesting that XRCC1 also participates in the A-NHEJ (Saribasak et al., 2011). Collectively, 
these results demonstrate a functional microhomology mediated end joining pathway which 
functions in cells lacking both DSB recognition and joining components of the classical NHEJ 
pathway (Boboila et al., 2010; Saribasak et al., 2011).  
 To elucidate the factors involved in A-NHEJ, a recent study examined the protein 
CTIP(Lee-Theilen et al., 2011). CTIP is a protein which participates in cell cycle 
control(Chinnadurai, 2006), DNA repair(Yun and Hiom, 2009), and resection of DSBs during 
homologous repair(Chen et al., 2008; Huertas et al., 2008). A shRNA construct was used to 
knockdown the expression of CtIP in a CH12F3 B cell line, resulting in a 40-60% defect in class 
switching compared to control cells, upon induction of CSR to IgA(Lee-Theilen et al., 2011).  
The knockdown of CtIP was also found to alter end joining during CSR, resulting in a 40% 
increase in blunt end joins in knockdown cells compared to wild type cells. When CtIP 
deficiency was combined with a deficiency in Ku, a significant decrease in CSR and increase in 
microhomology mediated joining was observed, suggesting that CtIP is promotes end joining 
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during CSR via the A-NHEJ mediated pathway (Lee-Theilen et al., 2011).
 
Figure 1-10: Isotype Switching Occurs via Class Switch Recombination at Switch Sequences: This 
figure illustrates class switch recombination (CSR) from IgM to IgE in the mouse IgH locus. Switch 
sequences (Sx) are found upstream of each Ig constant region exon (Cx). Sx are repetitive regions which 
are transcribed to initiate the CSR reaction. The single stranded DNA deaminase AID deaminates dC to 
dU  at  Sμ  and  Sε,   triggering  the  action  of  UNG,  which  removes  the  dU  and  creates  an  abasic  site.     The  
abasic site is repaired by AP endonuclease, which cuts the phosphodiester backbone and forms a break in 
the DNA. Repair by error prone polymerases followed by nucleotide excision repair protein processing 
creates double stranded breaks (DSBs).  DSBs are processed and repaired by proteins of the non 
homologous end joining (NHEJ) and alternative end joining (AEJ) pathway, leading to looping out of the 
intervening DNA. Recombination occurs  at  the  switch  sequences  leading  to  expression  of  Cε  (surface  IgE) 
 
 
1.3.5.6. Implications of DSB Repair During CSR 
 Introduction of a DSB into DNA is a threat to the genomic integrity of an organism. 
Since DNA damage is a common event in the cell which can arise due to a variety of factors, 
including induced DSBs during antibody diversification, a cellular DNA damage response 
pathway has evolved (Sancar et al., 2004). This pathway contains a network of proteins which 
recognize, identify, and respond to a DSB.  The reactions in the DSB response pathway include: 
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removal of the DNA damage, activation of a DNA damage checkpoint, a transcriptional 
response, and apoptosis (Sancar et al., 2004).  The DNA damage response proteins have been 
implicated in CSR to facilitate processing of the AID induced DSB.  Phosphorylated γ-H2AX 
and Nbs1 protein form nuclear foci at the CH region in cells undergoing CSR, and CSR is 
impaired in H2AX -/- mice.  Localization  of  phosphorylated  γ-H2AX and Nbs1 was dependent on 
AID, indicating that DSBs are intermediates in the CSR reaction (Petersen et al., 2001).  
Deficiency in Nbs1 resulted in a deficiency in class switching, independent of germline 
transcription, indicating a cell-intrinsic defect in recombination (Reina-San-Martin et al., 2005). 
Additionally, ATM kinase deficiency in mice also resulted in decreased levels of CSR but did 
not affect SHM, indicating it may participate in intra-switch region recombination (Reina-San-
Martin et al., 2004).  The   ATM   target   in   response   to   DNA   damage,   53BP1,   forms   γ-H2AX 
dependent foci at the IgH locus during CSR (Reina-San-Martin et al., 2004).  53BP1 is not 
required for efficient SHM, however, inactivation of 53BP1 completely eliminates CSR, 
implicating it in the joining phase of CSR (Manis et al., 2004). 
   
1.4. Activation Induced cytidine Deaminase (AID)   
 Diversification of the antibody repertoire relies on the activity of a single protein for both 
processes, SHM and CSR (Muramatsu et al., 2000).  AID belongs to the family of cytidine 
deaminases, and it is capable of deaminating dC to dU in vitro on both single stranded DNA 
substrates as well as RNA-DNA hybrids (Chaudhuri et al., 2003; Ramiro et al., 2003). As this 
protein is capable of introducing mutations into the DNA at a rate of up to 10-3 to 10-4 per base 
division (Liu and Schatz, 2009), a network of regulatory mechanisms is in place to control each 




1.4.1. Discovery  of  AID  as  “Mutator  Factor” 
 Studies of Ig genes in cartilaginous fish reveal extensive junctional diversity and somatic 
hypermutation, correlating the process of G-C mutation and Ig rearrangement at an early stage of 
vertebrate phylogeny (Cannon et al., 2004).  However, during evolution of the adaptive immune 
system, CSR was the last mechanism of the lymphocyte specific DNA modifications to evolve 
(Barreto et al., 2005), and there is no evidence of CSR occurring in cartilaginous or bony fish as 
they lack S regions upstream of the Ig regions which mediate recombination (Wakae et al., 
2006).   An AID homologue has been identified in fish with an SHM hotspot sequence, AGC/T 
Triplet, which is similar to the mammalian hotspot sequence of RGYW (Wakae et al., 2006). 
This fish AID, when ectopically introduced into E. coli or mammalian cells, is capable of 
mediating CSR, indicating that the protein has acquired most of the function to mediate CSR 
before the evolution of the IgH locus evolved S regions and additional constant regions, which 
are the targets of the CSR reaction (Barreto et al., 2005; Wakae et al., 2006).  Additionally, CSR 
evolved first in amphibians, which do not form R loops, and is AT rich (Du Pasquier, 2001) 
 AID was identified by subtraction hybridization cloning of cDNA derived from CH12F3 
lymphoma cells either unstimulated or stimulated for class switching (Muramatsu et al., 1999). 
These experiments revealed upregulation of a novel gene in the stimulated sets of CH12F3 cells, 
named activation induced deaminase (AID). The open reading frame of the AID cDNA encodes 
for a protein of 198 amino acids, or 24kDA, with  an amino acid sequence homologous to that of 
the mRNA editing enzyme catalytic peptide-1 (APOBEC-1), which suggested that AID may 
function as a RNA-editing deaminase rather than a DNA cytidine deaminase (Figure 1-11) 
(Muramatsu et al., 1999).  In addition to strong evolutionary conservation, AID and APOBEC-1 
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are located in close proximity on the same chromosomes (chromosome 6 and 12, in mouse and 
human, respectively) suggesting a gene duplication event occurred (Conticello et al., 2005). 
According the RNA editing model, if AID were to function as an RNA editing deaminase, AID 
and an associated cofactor would recognize a putative mRNA precursor and convert it to either 
an mRNA encoding an endonuclease or a molecule which would direct a pre-existing 
endonuclease to target sites (Muramatsu et al., 2007).  
 Further studies by the same group in which a germline AID deficient mouse strain was 
created demonstrated that a deficiency of AID completely blocks CSR and SHM in primary 
splenic B cells, although LPS activation still occurs (Muramatsu et al., 1999).  Germline 
transcript analysis of AID -/- primary splenic cells revealed expression of all isotypes in response 
to LPS with and without cytokines was similar to the response in AID +/+ and AID +/- splenic B 
cells (Muramatsu et al., 1999). This study considered both possibilities of AID functioning as 
either an RNA editing deaminase or a DNA cytidine deaminase.  
 Overexpression of AID in bacteria revealed a mutator phenotype, suggesting AID 
functioned as a DNA cytidine deaminase and directly acted on dC/dG pairs (Petersen-Mahrt et 
al., 2002). Conditions of uracil DNA glycosylase (UNG) deficiency enhanced mutation rate, 
further supporting the DNA deamination model (Petersen-Mahrt et al., 2002). Later studies 
provided additional support for the DNA deamination model by demonstrating that recombinant 
AID or AID purified from B cells could deaminate single stranded DNA in vitro (Bransteitter et 
al., 2004; Bransteitter et al., 2003; Chaudhuri et al., 2004; Chaudhuri et al., 2003; Dickerson et 
al., 2003). If AID acts directly on DNA, mutations of downstream repair factors should affect 
CSR and SHM. Consequently, inhibition of UNG by a bacteriophage encoded protein shifts the 
pattern of IgV mutations in chicken DT40 B cells from transversion to transition dominance, 
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providing evidence of DNA deamination (Di Noia and Neuberger, 2002). Mice deficient in UNG 
(ung -/-) display a similar phenotype, and display a substantial decrease in CSR efficiency to 
10% of that of ung +/+ mice, supporting formation of the DNA abasic site during switch 
recombination (Rada et al., 2002b).  
 If AID were to directly access the target DNA as proposed in the DNA deamination 
model, then it should be found in association with S region DNA.  Indeed, chromatin 
immunoprecipitation experiments from B cells stimulated for CSR reveal an in vivo association 
between AID and S region DNA which is specific for regions undergoing CSR (Chaudhuri and 
Alt, 2004; Nambu et al., 2003), providing further support for a DNA deamination model.  
 
 
Figure 1-11: Opposing Models for AID Mechanism of Action: Two models were initially proposed to 
explain the mechanism of action for AID.  The RNA Editing model was proposed due to the 
chromosomal proximity and protein homology of AID to RNA editing deaminase APOBEC1.  In this 
model, AID is proposed to act on an mRNA which encodes for an active endonuclease (or guide an 
existing endonuclease) to create a double strand break. However, experimental evidence has provided the 
most support for the DNA Deamination model, in which AID acts directly on deoxycytidine in DNA, 
deaminating to deoxyuridine, and with the assistance of base excision repair and mismatch repair 





1.4.2. Transcription of AID locus 
 The AICDA locus, encoding for AID, is composed of four distinct regions which control 
transcription (Figure 1-12) (Yadav et al., 2006). The promoters of both the mouse and human 
AICDA genes do not contain a TATA box, but do contain a lnr element around the major TSS, 
as well as upstream GC/GA boxes (Yadav et al., 2006).    The  first  region  (relative  to  the  5’  end  of  
the locus) is about 8kb upstream of exon 1 in mouse AICDA.  This region contains potential 
binding sites for NF-κB,   STAT6,   C/EBP, and Smad3/4 proteins, and may contribute to 




Figure 1-12: AID primary structure. A diagram of the primary structure of AID depicting the structural 
features of AID and functional relationships. NLS: Nuclear Localization Sequence; NES; Nuclear Export 




  AID transcript levels can be controlled by two miRNA molecules, miR-155 and miR-
181b. miR-155 is a regulator of lymphocyte homeostasis, contributing to the development of T 
regulatory cells (Kohlhaas et al., 2009), T helper cell differentiation (Thai et al., 2007), and 
germinal center response (Thai et al., 2007).  When a mouse strain was created in which miR-
155 was mutated in the binding region for AID regulation (Aicda155),  an increased half life of 
AID was observed, which led to an increase in the steady state levels of AID (Dorsett et al., 
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2008).  miR-181b also results in the down-regulation of AID mRNA and protein levels (de 
Yebenes et al., 2008). An overexpression of miR-181b results in impairment of CSR as a result 
of  direct  targeting  of  the  3’UTR  of  AID  (de Yebenes et al., 2008).  
 
1.4.4. Localization  
 For AID to deaminate DNA targets, it must be present in the nucleus.  Therefore, the 
nuclear:cytoplasmic localization of AID provides an additional layer of regulation. AID is 
predominant in the cytoplasm (Rada et al., 2002a), and is actively imported into the nucleus by a 
conformational positively charged nuclear localization signal (Patenaude et al., 2009) located at 
the N terminus (Ito et al., 2004). The C terminal region also contains a cytoplasmic retention 
sequence, which restricts nuclear entry, competes with nuclear import, and maintains the balance 
between nuclear import and cytoplasmic entry (Patenaude et al., 2009).  AID has also been 
shown to be exported from the nucleus due to a nuclear export sequence located at the C 
terminus (Ito et al., 2004).   
The stability of AID protein is related to its subcellular localization, as transfection of AID 
proteins expressing mutations in either the NLS or the NES show a differential accumulation as 
compared to wild type AID protein (Aoufouchi et al., 2008). Compared to wild type AID (half 
life 8 hr), cytoplasmic AID with a mutant NLS exhibits stronger expression and the longest half 
life (18-20 hr) , and nuclear AID with mutant NES exhibits the lowest expression and shortest 






1.4.5. Post-Translational Protein Regulation 
  Subcellular localization can also be regulated by controlled degradation mechanisms. A 
small fraction of AID has been shown to be polyubiquitinated in the nucleus (Aoufouchi et al., 
2008) of normal mouse B cells. Additionally, a transient transfection of AID into a human 
nonlymphoid cell line leads to ubiquitin-proteasomal mediated degradation of the protein.  
However, no specific lysine residue has been determined to be critical for ubiquitination 
(Aoufouchi et al., 2008).  
 AID from activated splenic B cells is phosphorylated, and this phosphorylation event 
allows interaction with replication protein A (RPA) (Chaudhuri et al., 2004). RPA binds ssDNA 
with very high affinity (Wold, 1997), and similarly, AID binds ssDNA with high affinity as 
compared to dsDNA (Chaudhuri et al., 2003).  Separately, neither RPA nor AID bound to the 
target (RGYW) SHM sequences in the absence of transcription.  When RPA and AID were 
combined in the presence of transcribed substrate, distinct DNA-protein complexes were formed, 
containing both AID and RPA (Chaudhuri et al., 2004). However, AID which is transiently 
expressed in nonlyphoid cell lines is not highly phosphorylated and does not interact with RPA 
(Chaudhuri et al., 2004), indicating the B-cell specificity of the AID-RPA interaction.  Further 
studies into the AID phosphorylation event provide insight into this B cell specificity by defining 
protein kinase A as the physiological AID kinase (Basu et al., 2005; Pasqualucci et al., 2006). 
Purified PKA from activated B cell extracts can impart upon AID expressed in non-lymphoid 
cells the ability to interact with RPA. Mass spectrometric analysis of purified nuclear AID from 
activated B cells identified residues serine 38 (S38) and tyrosine 184 (Y184) as sites of 
physiological PKA action, and sequence conservation analysis indicates threonine 27 (T27) may 
also serve as a site of potential PKA action (Basu et al., 2005).  CSR analysis reveals the 
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functional relevance of these residues in a retroviral complementation assay, during which wild 
type AID or mutant AID is introduced into AID -/- splenocytes stimulated to undergo CSR.  In 
this assay, introduction of AID(wt) or AID(Y184A) restored AID CSR function.  However, 
AID(T27A) or AID(S38A) did not rescue CSR, indicating these residues are required for PKA 
phosphorylation and AID mediated CSR in vivo (Basu et al., 2005). 
 Additional evidence that PKA activates AID was provided by in vitro overexpression 
studies of an epitope-tagged PKA catalytic subunit (PKA-Cα-A001914) (Vuong et al., 2009). 
Following LPS and IL4 stimulation, wild type splenic B cells which overexpressed this subunit 
expressed 40-50% higher levels of IgG1 than vector control wild type cells. Using chromatin 
immunoprecipitation, PKA catalytic subunit PKA-αC  was  found   to  be  recruited   to  Sμ  and  Sγ1  
regions following stimulation for CSR to IgG1. PKA regulatory subunit PKA-RIα  also  bound  to  
the active S regions, which suggested that the PKA holoenzyme was associated with the Igh 
locus (Vuong et al., 2009).  These associations were specific to cells which were stimulated for 
CSR as no association was detected in unstimulated cells or in proliferating splenic T cells.  
Chromatin immunoprecipitations using AID deficient splenic B cells retain PKA association to S 
regions, suggesting the PKA binding to S regions is AID-independent.  Two step chromatin 
immunoprecipitations reveal that AID, PKA, and RPA form a complex at S regions, which may 
function to initiate the early stages of CSR (Vuong et al., 2009).  
 
1.5. AID Substrate Targeting 
1.5.1. Transcription   
 AID is a single strand deaminase, requiring transcription to create access to ssDNA at 
sites of transcription bubbles and R loops (Chaudhuri et al., 2003; Yu et al., 2003). In vitro 
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cytidine deamination on T7 transcribed templates reveals a significant level of deamination 
occurs on the physiological nontemplate strand-C rich strand.  Only a modest amount of 
deamination occurs when the inverted G rich strand is transcribed (Chaudhuri et al., 2003).     
Strand specific analysis of reaction products from coupled transcription-deamination reactions 
reveals transcription targets AID deamination in an orientation dependent fashion, with 
deamination preferentially targeted to the displaced single strand of the R loop (non-template 
strand) (Chaudhuri et al., 2003).  However, analysis of ung -/- msh -/- mice indicates in the 
absence of UNG and MSH, there is no preference for AID targeting of the nontemplate over the 
template strand, suggesting that AID can deaminate both strands of DNA with equal frequency 
(Xue et al., 2006).   
 Both mechanisms of CSR and SHM absolutely require transcription of the target 
immunoglobulin locus sequence (Manis et al., 2002). Upstream of S sequences lie germline 
promoters (I promoters) which drive transcription in response to specific activators and 
cytokines. The transcripts produced from these promoters span through a non-coding I exon and 
intronic S sequences, and are polyadenylated downstream of the C exons. These transcripts are 
later spliced to fuse the I exon to the C region to produce the germline or sterile non-coding 
transcript. (Chaudhuri and Alt, 2004).  Gene targeting experiments in which I promoters or 
3’IgH  enhancer  elements  were  deleted  led  to  the  absence  or  reduction of germline transcription 
and corresponding CSR, illustrating the necessity of transcription for this process.  For example, 
deletion  of  Sγ1  results  in  a  nearly  complete  loss  of  CSR  to  background  levels,  0.4%  of  wild  type  
levels, and a predominant expression of IgG1a (Shinkura et al., 2003).   
Bidirectional transcription occurs from the IgH variable region exons, as well as from S 
regions, with transcripts produced in both the sense and antisense orientation having similar 
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expression patterns (Perlot et al., 2008).  Interestingly,  Cμ  exons,  located  between  the  VHDJH and 
are not targeted by AID, have only been found to be transcribed in the sense direction, indicating 
that antisense transcripts may contribute to AID targeting (Perlot et al., 2008).  However, using a 
transcriptional terminator cassette to provide polyA sites in both sense and antisense orientations 
(pAp cassette), it was determined that only the sense transcription through the switch regions is 
essential and sufficient for CSR, whereas the antisense transcription is dispensable (Haddad et 
al., 2011).  An  insertion  of  the  cassette  168bp  downstream  of  the  Iμ  exon  in  mice  (pApμ)  has  no  
effect on V(D)J recombination but leads to decreased GL transcription through  μ,  with   a  mild  
defect   in   CSR   to   downstream   isotypes.   An   insertion   251   bp   downstream   of   Iγ3   exon   (pApγ)  
leads  to  a  complete  and  specific  abrogation  of  CSR  to  IgG3  in  pApγ  mice  due  to  a  lack  of  sense  
transcription  from  Sγ3.  However,  an  insertion  500bp  downstream  of  Sγ3  core  repeats  (Sγ3-pAp), 
which transcribes in the sense direction only, results in normal CSR to IgG3 despite the absence 
of   Sγ3   antisense   transcription,   indicating   the   dispensability   of   antisense   transcription   for  CSR 
(Haddad et al., 2011).  
Inversion of S region sequences illustrates the dependence of S region function on 
transcript  orientation.      Inversion  of  Sγ1   results   in   a  decrease  of  CSR   from   IgG1a to IgG1b to 
25% of wild type levels, indicating a clear orientation dependence, likely due to the location of 
CSR junctions in S regions creating secondary structural elements (Shinkura et al., 2003).   
 During the process of transcription of S regions, stable RNA:DNA structures are formed 
which are resistant to RNAseA, phenol extraction, SDS-proteinase K, and heating to 65°C 
(Daniels and Lieber, 1995). Several secondary elements are formed, such as stable long R loops 
(>1 kb), in which a purine rich RNA strand pairs with a pyrimidine-rich DNA strand (Ruiz et al., 
2011; Yu et al., 2003). Other RNA secondary structures have also been shown to form at these 
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locations, such as stem loops (Tashiro et al., 2001).  These structural features can provide single 
strand substrates for AID (Ruiz et al., 2011). Ectopically expressed AID in a yeast THO mutant 
strain, which is defective in mRNP biogenesis and accumulates R loops, was able to deaminate 
cytosines on murine S region sequences and also led to a high level of chromosome 
translocations.  In contrast, a yeast strain defective for R loop formation, hpr1-101 did not show 
increased frequency of chromosome translocations (Ruiz et al., 2011).  
 Synthetic double stranded templates can only be deaminated by AID when coupled with 
transcription (Chaudhuri et al., 2003).  AID has been shown to physically interact with RNA 
polymerase II by direct immunoprecipitation (Nambu et al., 2003).  AID has also been shown to 
interact with cofactors of the RNA polymerase complex, including a component of paused RNA 
polymerase, Spt5 (Pavri et al., 2010).  
  
1.5.2.  Pathophysiology and Disease Models 
  Large scale DNA sequencing analysis (Liu et al., 2008) of Peyer’s  patch  B  cells  
from wild-type and AID-deficient mice reveals AID acts broadly on the genome, with action on 
genes outside of the immunogloubin locus.  Numerous genes linked to B cell tumorigeneisis are 
deaminated by AID, including Myc, Pim1, Pax5, Ocab, H2afx, Rhoh and Ebf1. However, a 
system of checks and balances put in place by the mismatch repair machinery and the error prone 
polymerases of the cell determines the distribution of AID-induced mutations throughout these 
loci (Liu et al., 2008). The homologous repair pathway is especially important in maintaining 
genome integrity.  A deficiency in both the homologous repair factor XRCC2 and AID leads to 
widespread, highly cytotoxic breaks throughout the genome (Hasham et al., 2010).  
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A second genomic screen (Pavri et al., 2010) of activated B cells revealed AID is 
associated with sites of Spt5 occupancy, a marker of stalled RNA polymerase II.  This analysis 
found   that  upon  genome  wide  analysis  of  Spt5  occupancy   in   the  promoter  proximal   region,   Iμ  
showed the strongest AID occupancy signal, followed by the IgH enhancer region. Strikingly, 
AID was recruited to sites of Spt5 localization that were not located within the Ig locus, and AID 
occupancy and mutation frequency at these sites correlated with Spt5 occupancy (Pavri et al., 
2010). 
 Chromosome translocations between the IgH locus and c-myc oncogene are characteristic 
of   the   human   B   cell  malignancy   Burkitt’s   lymphoma (Leder et al., 1983). Closer analysis of 
these translocations reveals that most of these translocations involve IgH switch region DNA, 
suggesting these translocations result as an aberrant product of normal CSR mechanisms (Adams 
et al., 1982; Taub et al., 1982). Mice deficient in CSR enzyme AID in an IL6 transgenic 
background (AID IL6tg) were examined for IgH-c-myc translocations.  B cells were compared at 
similar stages of development; multiple translocations of IgH/c-myc were detected in AID+/-Il6tg 
mice, however, none were detected in the AID-/-Il6tg mice, indicating that AID contributes to the 
genomic instability in B cells by mediating IL6 induced c-myc/IgH translocations in vivo 
(Ramiro et al., 2004). 
 Using an AID-oestrogen receptor inducible retroviral construct to transduce AID-/- 
primary B cells, IgH/c-myc translocations can be induced within hours of induction of AID 
expression (Ramiro et al., 2006).  AID induced translocations also require UNG, as this enzyme 
removes the introduced uracil, resulting in abasic sites necessary for the double strand break.  
However, enzymes of the NHEJ pathway which are required for AID mediated CSR and SHM, 
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including histone H2Ax, p53 binding protein 1 (53BP1) and Ku80, are not required for AID 
induced chromosomal translocations (Ramiro et al., 2006).  
Increased IgH translocations have been found in B cells deficient in tumor suppressor 
proteins ATM, Nbs1, p19Arf, and p53, which have been activated for class switching (Franco et 
al., 2006; Ramiro et al., 2006). As these IgH translocations are inhibited by these tumor 
suppressor proteins, it is suggested that the translocations proceed through activation of DNA 
damage and genotoxic or oncogenic stress induced pathways (Ramiro et al., 2006).  AID has also 
been shown to be involved in solid tumor models by introducing chromosomal translocations at 
oncogenes involved in prostate cancer, TMPRSS2:ERG and TMPRSS2:ETV1 as a result of 
genotoxic stress (Lin et al., 2009). 
Transgenic AID mice (Tg) expressing AID constitutively and ubiquitously develop 
tumors in various organs, including the liver, lungs, and lymphoid tissues (Endo et al., 2007; 
Kotani et al., 2005; Morisawa et al., 2008; Okazaki et al., 2003).  Tg mice have shorter life spans 
than wild type littermates, due to enlarged lymphoid tissues caused by diseases such as 
lymphoblastic lymphoma and malignant T cell lymphomas. These malignant lymphomas also 
invade nearby nonlymphoid organs, such as liver, kidney, and lung (Okazaki et al., 2003). Tg 
mice also develop cancers of non-lymphoid origin, including hepatocellular carcinoma (Endo et 
al., 2007), gastric adenomas (Morisawa et al., 2008), and lung adenocarcinomas (Okazaki et al., 
2003).  Sequencing of the rearranged and expressed TCR genes from these mice revealed large 
amounts  of  point  mutations  in  the  Tg  mice,  especially  in  the  Vβ  sequences, whereas almost no 
point mutations were found in the wild type littermates. In addition, non-Ig genes such as c-myc 
and pim1 also accumulated mutations in the Tg mice (Endo et al., 2007; Okazaki et al., 2003).  
Analysis of gene expression profiles of tumor related genes reveals organ specific genetic 
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changes associated with AID overexpression; c-myc nucleotide changes are observed in 
lymphoid and lung cancers but not in liver and stomach cancers.  Similarly, the oncogene Afp is 
expressed and upregulated only in HCC cells, but not in lung or gastric cancer cells (Morisawa et 
al., 2008).   
 Deficiency in AID in humans leads to the autosomal recessive form of the immune 
syndrome hyper-IgM syndrome (HIGM2). This disease is characterized by three major 
abnormalities: (1) the absence of immunoglobulin CSR, (2) the lack of immunoglobulin SHM, 
and (3) lymph node hyperplasia caused by giant germinal centers (Revy et al., 2000). Sequencing 
of the defective huAID gene in HIGM2 patients reveals that widely scattered point mutations in 
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Strands of Transcribed Duplex DNA Substrates 
 
2.1. The RNA Exosome  
 The   exosome   is   a   multisubunit   complex   with   3’Æ 5’   exoribonuclease activity which 
functions to process a variety of cellular RNA substrates for degradation (Mitchell et al., 1997; 
Wang and Kiledjian, 2001).  In addition to degradation, the exosome also processes stable RNAs 
such as small nucleolar and small nuclear RNAs (Allmang et al., 1999a).  
 
2.1.1. Structure  
 The eukaryotic exosome is composed of a core of six proteins which oligomerize to form 
a ring with a central pore large enough to accommodate one single stranded RNA molecule at a 
time (Lorentzen et al., 2005). This core is capped with a three-component cap (Januszyk and 
Lima, 2011; Lorentzen et al., 2005). See Table 2-1 for nomenclature and Figure 2-1 for 
structure. RNAse PH domains are conserved across the six core proteins of both archaeal 
exosomes and eukaryotic exosomes, as well as conserved between bacterial RNase PH and 
PNPase PH exoribonucleases. These domains activate inorganic phosphate as a nucleophile to 
release  ribonucleoside  5’diphosphate (Januszyk and Lima, 2011; Liu et al., 2006; Symmons et 
al., 2000). Both archaeal and eukaryotic exosomes also contain putative KH and S1 RNA 
binding domains, located in the three component cap subunits (Buttner et al., 2005; Liu et al., 
2006).   
 Rrp44p is the tenth yeast subunit (Mitchell et al., 1997), but the human counterpart, 
Dis3p, is not present in exosome preparations (Allmang et al., 1999a).  Therefore, the tenth 
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human subunit (and eleventh yeast subunit) is the  3’Æ5’  exoribonuclease  sharing  similarity   to  
RNAse D, Rrp6p, which is associated with nuclear exosome preparations (Burkard and Butler, 
2000). Rrp6p has been found to interact with poly(A) polymerase and with Npl3p, a poly(A)+ 
mRNA binding protein, suggesting that Rrp6p may interact with mRNA polyadenylation system 
and participate in degradation of abberantly processed precursor mRNAs (Burkard and Butler, 
2000). 
 None of the human or yeast subunits of the core nine component exosome individually 
possess phosphorolytic exoribonuclease activity (Liu et al., 2006), which may be due to the lack 
of conservation of residues required for RNA binding in catalysis in the RNAse PH domain 
subunit proteins (Lorentzen and Conti, 2005). Of the total eleven yeast subunits, ten are essential 
for viability. The remaining non-lethal subunit, Rrp6p, results in a temperature-sensitive lethality 
(Allmang et al., 1999b).  
  Rrp44p (Dis3p) is the only subunit which retains processive hydrolytic activity 
associated with the cytoplasmic exosome (Januszyk and Lima, 2011; Liu et al., 2006). Rrp44p 
hydrolyzes  one  nucleotide  at   a   time   in   the  3’Æ5’  direction   in  a   sequence   independent  manner 
(Lorentzen et al., 2008).  Yeast Rrp44p is present in both the nuclear and cytoplasmic exosome 
complexes, and is essential for cell viability (Allmang et al., 1999b; Mitchell et al., 1997). 
Although homologues of yeast Rrp44p have been found in the human genome, they have not 
been detected to be associated with the human exosome core (Liu et al., 2006). Yeast Rrp6p 
exhibits distributive activity (Burkard and Butler, 2000; Liu et al., 2006), with similar activity 
detected for human Rrp6p. An eleven subunit exosome complex (yExo11) reconstituted to 
contain all subunits including Rrp6p and Rrp44p generates products consistent with both the 
distributive Rrp6p and processive Rrp44p activities (Liu et al., 2006). Assessment of the RNase 
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PH-domains reveal that a Rrp41p/45p heterodimer possesses phosphate-dependent activity and 
produces an RNA product of 4-5 nucleotides, which is consistent of products formed by bacterial 
PNPase.  No other subunit heterodimers were found to possess this PNPase activity (Liu et al., 
2006).  
 
Figure 2-1: Structure of Eukaryotic RNA Exosome: The exosome is composed of a nine subunit core 
containing subunits Csl4, Rrp4, Rrp40, Rrp41, Rrp46, Mtr3, Rrp42, Rrp43, and Rrp45.  The RNA 
Exosome core has RNA binding activity but lacks exoribonuclease activity.  Exoribonuclease activity is 










Exosc4 (35%) essential Core – PNPase RNase PH2-like 
Rrp45p PM-Scl75 (38%), 
Exosc9 
essential Core - PNPase RNase PH1-like 
Rrp42p Exosc7 (25%) essential Core - PNPase RNase PH1-like 
Rrp43p Exosc8 essential Core - PNPase RNase PH1-like 
Mtr3p Exosc6 essential Core - PNPase RNase PH2-like 
Rrp46 Exosc5 (35%) essential Core - PNPase RNase PH2-like 
Rrp4p Exosc2 (43%) essential Cap – RNA binding S1 domain 
Rrp40p Exosc3 (43%) essential Cap – RNA binding S1 domain 
Csl4p hCs14p (48%) Essential  Cap – RNA binding S1 domain  
Rrp44p hDis3p (45%) Essential Processive hydrolytic exoribonuclease 
Rrp6p Exosc10,     PM/Scl-
100 (32%) 
Ts lethal Distributive hydrolytic exoribonuclease 
 
Table 2-1: Core and Catalytic Subunits of the Exosome: Core and catalytic subunits of the yeast 
exosome are listed in right column with human homologue and percent homology noted.   Phenotype as 




2.1.2. Substrate Preference 
  Synthetic   substrates   of   49   nucleotides   were   generated   to   contain   3’AU   rich,   poly(A),  
generic RNA or mixed sequence RNA  (a combination of the three). Human Rrp41p/Rrp45p 
heterodimer (yeast subunits Rrp44p and Rrp6p) preferentially   bound   the   3’AU   rich   substrate.    
Yeast  10  and  11  subunit   exosome  preparations   (yExo10  and  yExo11)  also  preferred   the  3’AU  
rich substrate (Liu et al., 2006).   
Substrate preference was also assayed with synthetic RNA substrates containing 
secondary  structures  of  a  20nt  GNRA  stem  loop  with  3’AU  rich  extension  of  varying base pair 
length.  Human Rrp41p/45p heterodimer  required  the  3’AU  extension  to  be  at  least  10nt  long  for  
catalytic activity to occur.  Yeast Rrp44p exhibited processive activity on this structured 
substrate  but  only  with  a  long  3’AU  end  of  20-29bp, suggesting  the  free  3’end  is  necessary  for  
activity of Rrp44.  Yeast Rrp6p exhibited   activity   only   on   the   3’AU   end,   and   distributive  
hydrolysis stopped at the point of reaching the stem loop, suggesting that structured substrates 
are poor substrates for Rrp6 (Liu et al., 2006).  
 UV crosslinking studies (Wlotzka et al., 2011) were performed to identify target RNAs of 
the nuclear RNA surveillance machinery, including the RNA exosome and associated cofactors.  
This screen identified targets with known binding sites, including small nucleolar RNAs 
(snoRNAs), pre-mRNAs, and cryptic, unstable non-protein coding RNAs (ncRNAS, or CUTs). 
Also identified were predicted long antisense ncRNAs (asRNAs), intergenic ncRNAs and 
mRNAs. Targets were generally enriched with non-encoded 1-5nt polyadenylated tails (Wlotzka 
et al., 2011).   
The exosome is also an essential component of generation of 5.8s rRNA, as mutation of 
Rrp4p or Rrp6p using a temperature sensitive allele in S. cerevisiae has identified the exosome as 
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necessary for processing of  the  3’end of the 7s pre-rRNA to generate 5.8s rRNA (Briggs et al., 
1998; Mitchell et al., 1997).  The exosome complex, in combination with cofactor TRF4, is 
involved  in  3’  end  trimming  and  modification of pre-tRNAMET to mature tRNA (Kadaba et al., 
2004).  This modification defective tRNAMET was stabilized by a mutation in the poly(A) 
polymerase Trf4p or by mutations in exosome components Rrp6p,Rrp44p,or Dis3p, indicating 
that the exosome and its cofactors are required for polyadenylation and degradation in the tRNA 
surveillance pathways (Kadaba et al., 2004). 
RNAs which are derived from nonannotated regions of the genome are degraded rapidly 
and efficiently by the nuclear exosome.  These RNAs, transcribed by RNA polymerase II, are 
designated as CUTs, or Cryptic Unstable Transcripts (Thiebaut et al., 2006). CUTs accumulate 
as 300-600nt transcripts in a Rrp6p deficient yeast strain, resulting from their stabilization rather 
than transcriptional activation (Wyers et al., 2005).  
 
2.1.3. Cofactors  
 Purified exosome preparations show weak in vitro activities, indicating that RNA 
degradation at physiological rates requires activating cofactors (LaCava et al., 2005). 
Individually most of the subunits are inactive, with the exception of Rrp44p/Dis3p, which shows 
processive activity in vitro (Mitchell et al., 1997), which suggests a mechanism of activation 
exists to prevent premature or nonspecific degradation (LaCava et al., 2005). The essential ATP-
dependent RNA helicase Dob1p(Mtr4p), was the first cofactor identified to functionally interact 
with the exosome complex and may participate in the local unwinding of secondary RNA 
structure (de la Cruz et al., 1998; Liang et al., 1996).  Yeast strains containing mutations in 
dob1/mtr4  lead to a deficiency in 60S ribosomal subunits, impaired pre-rRNA processing, 
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nuclear poly(A)+ accumulations (de la Cruz et al., 1998; Liang et al., 1996). Northern 
hybridizations to pre-rRNA spacer fragments in rrp4 deficient and proficient strains indicate that 
Mtr4p  functionally  interacts  with  Rrp4p  for  efficient  turnover  of  the  5’spacer  pre-RNA fragment 
(de la Cruz et al., 1998).   
 Nuclear surveillance factors Nrd1 and Nab3 form a complex (Nrd1-Nab3 complex) 
which functions in transcription termination of a variety of small RNA substrates transcribed by 
RNA Polymerase II, including snoRNAs, CUTS, and also selected mRNAs (Arigo et al., 2006a; 
Arigo et al., 2006b; Thiebaut et al., 2006).  The Nrd1-Nab3 complex also functions as an 
exosome cofactor by promoting degradation of CUTs and participating in 3’end  processing  of  
snoRNAs (Arigo et al., 2006b; Thiebaut et al., 2006). 
 Mtr4p was later identified by yeast two hybrid analysis as part of a multisubunit complex 
which collectively functions to activate the exosome.  This complex, the TRAMP complex, is a 
nuclear polyadenylation complex composed of Mtr4p, a poly(A) polymerase Trf4p, and a zinc 
knuckle protein, Air2p (LaCava et al., 2005). Trf4p polyadenylates the RNA substrates, assisted 
by Air2p, which is thought to assist Trf4p by recruiting the complex to target RNAs via RNA or 
protein interactions (Jia et al., 2011; LaCava et al., 2005). This polyadenylation must differ from 
that of poly(A)polymerase action to stabilize RNA so that the exosome can recognize the 
substrate signal.  Using reconstituted S. cerevisiae TRAMP, it was demonstrated that the poly(A) 
tail length is restricted to 3-4 adenosines (Wlotzka et al., 2011) by the action of Mtr4p (Jia et al., 
2011).  Mtr4p accomplishes this restriction by modulating individual adenylation rate constants 
and  ATP  affinities,  depending  on  the  number  of  3’terminal  adenosines  which  have  been  added 
(Jia et al., 2011).  
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 However, the helicase activity of Mtr4p is also important in polyadenylation of 
substrates, as a mutation in the helicase motif generates longer poly(A) tails than wild type, and 
lacks coordination in adenylation rate constants and ATP affinity, suggesting that Mtr4p requires 
coordination between both its RNA and ATP binding sites for efficient function (Jia et al., 2011).  
 In vitro substrate degradation is stimulated and shows higher activity upon addition of 
TRAMP complex to exosome preparations.  In vivo activity was also demonstrated using yeast 
strains individually deleted for TRAMP components, in which 23S pre-rRNA   and   3’extended  
forms of U14 snoRNA accumulated in these mutants (LaCava et al., 2005), a phenotype 
mirrored in exosome component deletion strains (Allmang et al., 1999a).   
 
2.2. Rationale of the Study 
 AID is a single stranded (ss)DNA specific cytidine deaminase that lacks activity on 
double stranded (ds)DNA (Chaudhuri et al., 2003; Dickerson et al., 2003; Ramiro et al., 2003; 
Sohail et al., 2003).  The lymphocyte-specific processes CSR and SHM require transcription 
through (ds)DNA substrate V(D)J exons or S regions to target AID activity to these regions.  
Transcription through S regions creates a (ss)DNA AID substrate through the generation of R 
loops, in which the template strand is hybridized to the nascent transcript, and the nontemplate 
strand is looped out as (ss)DNA (Daniels and Lieber, 1995; Shinkura et al., 2003; Tian and Alt, 
2000; Yu et al., 2003). In vitro transcription generated R loops provide substrates for AID but 
only on the nontemplate strand (Chaudhuri et al., 2003). AID phosphorylated on serine 38 by 
protein kinase A can access in vitro transcribed (ds)DNA SHM substrates that lack the ability to 
form R loops, however, this activity is also on the nontemplate strand (Basu et al., 2005; Basu et 
al., 2008; Chaudhuri et al., 2004; Vuong et al., 2009; Zarrin et al., 2004).  Ectopically expressed 
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AID can mutate transcribed substrates in bacteria and in yeast but this action also occurs only on 
the nontemplate strand (Ramiro et al., 2003; Ruiz et al., 2011).  Therefore, the mechanism of 
how AID accesses and deaminates the template has been a major and unresolved question 
(Chaudhuri et al., 2007; Di Noia and Neuberger, 2007; Liu and Schatz, 2009; Maul and Gearhart, 
2010; Pavri et al., 2010) which we seek to address.  
 
2.3. Experimental Design 
 To elucidate factors that might promote AID access to the template strand of transcribed 
substrates in the context of RNA/DNA hybrid structures, we in vitro transcribed an RGYW-rich 
dsDNA SHM substrate with T7 RNA polymerase in the presence of Ramos human B cell 
lymphoma line extracts.  Transcribed DNA-protein complexes were purified via 
chromatographic steps (Figure 2-2A) that would enrich for DNA binding (CM-Sepharose, 
DEAE cellulose) and macromolecular complex formation (gel filtration chromatography), 
followed by heparin sepharose chromatography and anti-AID mediated affinity purification to 
enrich complexes containing AID. Complexes were electrophoresed by SDS-PAGE and stained 
by Coomassie blue (Figure 2-2B).  Protein bands were isolated and identified by mass 









Figure 2-2: Purification and Isolation of the AID Associated Complexes             
(A):  Purification scheme for isolation of AID-associated complexes 
(B): Proteins enriched by purification scheme in (A) were analyzed by SDS-PAGE 
followed by staining with Coomassie Blue. Identity of proteins from selected bands was 
determined by mass spectrometry analysis; bands that contain RNA exosome subunits 
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Select Summary Report (MS09365 3)   
OIP2/ExoSc8 3 
Select Summary Report (MS09365 5)   
OIP2/ExoSc8 20 
OIP2/ExoSc8 5 
Select Summary Report (MS09365 6)   
Rrp42/ExoSc7 24 
Rrp40/ExoSc3 32 
Select Summary Report (MS09365 7)   
OIP2/ExoSc8 18 
Rrp40/ExoSc3 18 









Table 2-2: RNA Exosome Subunits Found in the AID-Associated 






2.4.1. AID Forms a Transcription Dependent Complex with RNA Exosome       
 To reveal potential functions of the AID-associated complex we assayed the ability of the 
complex to support AID-mediated deamination using purified AID in a transcribed dsDNA SHM 
substrate assay (Chaudhuri et al., 2003). Addition of the complex distinctly stimulated AID 
activity (Figure 2-3)  
 
Figure 2-3: AID Forms a Transcription Dependent Complex with RNA Exosome      AID 
purified following ectopic expression in HEK293 cells was assayed in a 3H release in vitro 
transcription-dependent SHM substrate assay (Chaudhuri et al., 2003) in the presence or absence of 
complex enriched by purification scheme in Figure 2-2. Percent of total transcribed DNA substrate 
deaminated is presented for three separate assays.  
 
 Initial AID-associated complex purification was also performed in absence of T7 
polymerase. However, AID association with the RNA exosome was not observed in the absence 






Figure 2-4: AID-Associated Complex Formation is Transcription Dependent. Enrichment of AID-
Associated complex generated in a T7 transcription dependent SHM substrate in the presence of 
Ramos cell extracts show the transcription and AID-dependent dsDNA deamination activity of the 
purified protein factors obtained from incubation of Ramos extract, and SHM substrate followed by 
elution via a carboxy-methyl sepharose column.  Note that a highly active AID complex is eluted from 
the column when the reaction contains T7 polymerase (right) but not when the reaction lacks T7 
polymerase.     Load:   samples   loaded  onto   the  CM  column;;  PT:   “Pass  Through”  of  CM  column;;  W1:  
first wash of CM column, W2: second wash of CM column, El.: Elution from CM column (fraction). 
“+T7”   and   “-T7”   represent   substrates   with   and   without   transcription   of   T7   polymerase.      Values  
represent average and standard deviation from the mean from three independent experiments. 
 
 AID was immunoprecipitated from mouse primary splenic B cells stimulated with anti-
CD40 and IL-4 to induce CSR to IgG1 to analyze in vivo association between AID and RNA 
exosome. Immunoprecipitates were analyzed by western blotting with specific antibodies to 
RNA exosome subunits.  These analyses revealed that AID associated with Rrp40, Rrp46, and 
Mtr3 exosome subunits (Figure 2-5A). AID was also immunoprecipitated from mouse 
lymphoma cell line CH12F3 stimulated with anti-CD40, IL-4, and TGF-β.   These   analyses  
revealed an association of AID with exosome subunits Rrp40, Rrp46, and Rrp6 (Figure 2-5B). 
Together, these analyses demonstrate an association in vivo of AID and RNA exosome, either 







Figure 2-5: AID Complexes with RNA Exosome Subunits in Vivo:  
(A): AID immunoprecipitates from extracts of CSR-activated AID-deficient and wild-type B 
cells were assayed for Rrp40, Rrp46, Mtr3, and AID (indicated on the right) via western blotting.  
The left two lanes show western blotting of total extract, and the right two lanes show western 
blotting of immunoprecipitated products.   
(B): AID immunoprecipitates “Anti-AIDIP”   lanes   or   control   reactions   without   anti-AID 
antibody   “-AbIP”   lanes   from   Ramos   and   CSR-activated   CH12F3   cells   “CH12F3   Sti” were 
assayed for Rrp46, Rrp40, Mtr3, and AID (indicated on the right) by western blotting.  
Unstimulated  CH12F3  “CH12F3  unsti”  was  used  as  a  negative  control.  
 
2.4.2. Exosome Core Subunit Rrp40 is Required for Optimal CSR 
 To evaluate potential functional roles of the RNA exosome in CSR, we used a knock 
down approach to reduce Rrp40 in the CH12F3 B cell lymphoma line.  This cell line was chosen 
because class switching at a high frequency (>45% after 72 hours) from IgM to IgA can be 
induced using IL-4,  TGFβ,  and  anti-CD40 (Nakamura et al., 1996), therefore providing a model 
system for the study of CSR. To accomplish the knockdown, we used lentivirus infection 
tointroduce two different shRNAs which targeted Rrp40 into the CH12F3 line to generate three 
different knockdown lines. Rrp40 levels ranged from 10-50% of controls (Figure 2-6B).  
Controls included both wild type CH12F3 cells as well as wild type cells transduced with a 
nonspecific  “scrambled”  shRNA lentiviral construct. All lines were stimulated with anti-CD40, 
IL-4, and TGF-β   to   induce   CSR   to   IgA.      Following   stimulation,   Rrp40   knockdown   lines  
displayed reduced CSR with levels of 30-50% of wild type levels, while expressing similar 
levels of AID (Figures 2-6A and 2-6C).  Cell lines were analyzed for proliferation using trypan 
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blue staining; analysis showed Rrp40 knockdown lines proliferated similarly to controls after 
stimulation (Figure 2-6E). Analysis of germline transcripts from Rrp40 lines show expression of 
similar  levels  of   Iμ  and  Iα transcripts (Figure 2-6D).  Collectively, these analyses demonstrate 
that knockdown of Rrp40 does not affect cell proliferation or transcript levels, however, 














Figure 2-6: RNA Exosome Subunit Rrp40 is Required for Normal CSR 
(A):CH12F3 cells transduced with lentivirus containing a scrambled short-hairpin plasmid (NS) or 
with  shRNA  against  Rrp40  (shRrp40  were  either  not  stimulated  (“Unsti”)  or  stimulated  (“Sti”)  for  
2 days with anti-CD40,   IL4,   and   TGFβ   and   analyzed   for   CSR   to   IgA   by   flow   cytometry.   Sh-
Rrp40-1 and sh-Rrp40-2 are independent sh-Rrp40 expressing CH12F3 isolates. Results are 
representative of eight experiments.  
(B): NS, shRrp40-1, and shRrp40-2 expressing stimulated and unstimulated CH12F3 isolates 
(shown in A) were assayed for Rrp40 and AID by western blotting.  Results are representative of 
four experiments 
(C): Average levels and standard deviation from the mean of CSR to IgA from three independent 
experiments   (one   shown   in   A)   performed   simultaneously   with   unstimulated   “unsti”   NS   and  
stimulated  “sti”  NS,  shRrp40-1(#1) and shRrp40-2(#2) CH12F3 isolates.  
(D): Total cellular RNA from three independently stimulated samples of indicated CH12F3 
isolates   (the  ones   used   for  C)  was   assayed   for   Iμ transcripts   (left)   and   Iα   transcripts   (right)   via  
quantitative RT-PCR.  Average and standard deviation from the mean is shown for the three 
separate experiments. 
(E): Growth curves of stimulated shRrp40-1 and shRrp40-2 CH12F3 cells calculated from three 







2.4.3. Association of Rrp40 with S Regions in B Cells Activated for CSR 
 To evaluate putative function of the RNA exosome as an AID targeting factor, we 
evaluated its potential to associate with transcribed S regions in activated B cells. We performed 
chromatin immunoprecipitation to test whether Rrp40 associates with transcribed S regions in 
activated CH12F3 cells before and after stimulation for CSR to IgA. To confirm the specificity 
of the Rrp40 antibody, we first analyzed immunoprecipitates using western blotting to confirm 
that Rrp40 is specifically precipitated, but not control IgG, under conditions of chromatin 
immunoprecipitation (Figure 2-7A). Immunoprecipitates were then processed for isolation of 
bound  DNA.  We  performed  quantitative  PCR  to  determine  levels  of  Rrp40  bound  to  Sμ  and  Sα.    
Analyses  of  these  regions  revealed  enrichment  of  Sμ  and  Sα  (albeit  to  a  lesser  extent)  in  the  anti-
Rrp40 chromatin immunoprecipitates from stimulated cells as compared to unstimulated cells 
(Figure 2-7B).  However,  there  is  a  small  amount  of  Sμ  transcription  detected  from  unstimulated  
CH12F3 cells (Muramatsu et al., 2000), so to determine whether transcription is sufficient to 
recruit the RNA exosome to S regions we performed chromatin immunoprecipitation in WT and 
AID-deficient primary B cells activated with anti-CD40 and IL-4,  which   induces  germline  Sγ1  
transcription in both cell types (Muramatsu et al., 2000). We assayed both cell types for Rrp40 
recruitment  to  Sμ  and  Sγ1  and  found  that  Rrp40  was  recruited  to  Sμ  and  Sγ1  in  the  activated  WT  
cells (Figure 2-7D), consistent with transcription-dependent targeting.  Strikingly, Rrp40 
recruitment was not detected at  Sμ  and  Sγ1  regions  in  AID  deficient  cells (Figure 2-7C & D), 
indicating that the RNA exosome complex is recruited to transcribed S regions in B cells 
activated for CSR in an AID dependent fashion.  
N.B.: Since completion of this work presented in this chapter, part of this work has been 











Fig 2-7: RNA Exosome Subunit Rrp40 is Recruited to S Regions 
(A): CH12F3  cells  were   either   stimulated  with  TGFβ,   IL4,   and  CD40  or   kept  unstimulated   for  
48hr.  Subsequently, Rrp40 was immunoprecipitated from cell extracts under chromatin 
immunoprecipitation conditions (ChIP) and immunoprecipitates analyzed for Rrp40 by western 
blotting with anti-Rrp40.  
(B): The ChIPed Rrp40-DNA complex from CH12F3 cells was processed to isolate bound DNA.  
ChIPed  DNA  was  tested  for  Sμ  and  Sα  sequences  via q-PCR. The average and standard deviations 
from the mean for three separate ChIP experiments are shown.  Numbers indicate average fold 
changes comparing stimulated and unstimulated samples.  Unstimulated samples were arbitrarily 
normalized as 1.  
(C): Rrp40 ChIPs were performed on extracts from primary splenic B cells stimulated for 2 days 
with anti-CD40  plus  IL4.  Sμ  and  Sγ1  were  tested  via  semiquantitative  PCR;;  results  are  shown  for  
two independent ChIP samples for each genotype.  A 5-fold serial dilution of inputs is shown with 
the highest input concentration corresponding to 1/20 of total input.  
(D): ChIPed  DNA  from  activated  splenic  B  cells  was  tested  for  Sμ  and  Sγ1  via  q-PCR.  Numbers 
indicate average fold changes comparing WT and AID -/- samples.  AID-/- samples were 
arbitrarily normalized as 1.  Values represent the average and standard deviation from the mean 





2.5. Materials and Methods 
2.5.1. Recombinant Plasmids, Antibodies, and Proteins 
 The RNA exosome recombinant subunits (Csl4, Mtr3, Rrp4, Rrp40, Rrp42, Rrp43, and 
Rrp46, Rrp6, Rrp41 and Rrp45) were previously published or cloned in pRS-DUET vector for 
expression of His6-tagged recombinant proteins. AID was expressed in 293T cells using 
construct pcDNA-AID as previously described (Chaudhuri et al., 2004; Chaudhuri et al., 2003; 
Greimann and Lima, 2008). Recombinant RPA was expressed from vectors p11d-RPA plasmid 
provided by B. Stillman (Stillman and Gluzman, 1985). AID antibodies were generated as 
previously described (Chaudhuri et al., 2003). Other antibodies were obtained as follows: Rrp40 
(Genway);Rrp6 (Genway); Rrp46 (AbCam); Mtr3 (Genway). The recombinant RNA exosome 
subunits  and  RNA  exosome  complex  was  puriﬁed  as  described (Greimann and Lima, 2008). 
 
2.5.2. AID Transcription-Dependent 3H-Release DNA Deamination Assay 
 For the uracil release assay, a [3H]-labeled DNA (1–2 pmol) substrate was transcribed 
using T7-Maxiscript kit (Ambion) and incubated with 1 mg of AID 293 protein preparation and 
indicated additional factors as described (Basu et al., 2005; Basu et al., 2008; Chaudhuri and Alt, 
2004) or  indicated  in  relevant  ﬁgure  legends.  The  RGYW-rich  artiﬁcial  SHM  substrate,  R-loop 
artiﬁcial   substrate   and   Sm   substrate   were   assayed as described previously (Basu et al., 2005; 
Basu et al., 2008; Chaudhuri et al., 2004; Chaudhuri et al., 2003). For comparison purposes, the 
optimal concentration for activity of different enriched cellular or recombinant core exosome 
protein components used for this assay was determined by titrating varying amounts of the RNA 
exosome preparations in the 3H-release DNA deamination assay with other conditions remaining 
ﬁxed (Appendix 7.1). The deaminated DNA products were then deglycosylated with 
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recombinant bacterial UDG (0.2 units, New England Biolabs) for 1 h at 37 C in a buffer 
containing 25 mM Tris-Cl, pH 7.5, 100 mM NaCl, 1 mM DTT and 10 mM ZnCl2. The reaction 
was terminated by 1%TCA precipitation, centrifuged, and the radioactivity retained in the 
supernatant counted via liquid scintillation counter (Wallac 1409). DNA deamination activity 
was expressed as a percentage of TCA soluble to total [3H] counts in the input DNA substrate. 
More details on the assay have been described previously (Chaudhuri et al., 2004; Chaudhuri et 
al., 2003) 
 
2.5.3. Strand-Speciﬁc  AID  DNA  Deamination  Assay 
 Transcription of the RGYW-rich sequences was performed with a T7-Maxiscript kit 
(Ambion) using approximately 100 ng of substrate DNA. To determine which strand of the 
RGYW DNA was deaminated, after incubation with AID plus additional test factors (e.g., RNA 
exosome/exosome subunits/RPA and PKA) the DNA was de-glycosylated and de-proteinated 
with proteinase K, treated with hot alkali and then precipitated. Denaturation and Southern 
analysis  of  the  DNA  was  done  using  speciﬁc  probes  designed  to  recognize  the  T7  primer  binding  
sequences.  Probes  used  in  the  Southern  analysis  hybridize  to  the  5’  end  of  non-template strand or 
the  3’end  of  the  template  strand,  respectively.  The probes are labeled with [g-32P]ATP using T4 
polynucleotide kinase (Chaudhuri et al., 2004; Chaudhuri et al., 2003). The RGYW-rich  artiﬁcial  
SHM substrate, R-loop   artiﬁcial   substrate   and   Sm   substrate   assayed   as   described previously 
(Basu et al., 2005; Basu et al., 2008; Chaudhuri et al., 2004; Chaudhuri et al., 2003) 
 
2.5.4. Puriﬁcation  of  RNA  Exosome  Complex  from  293T  Cells 
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 A 293T cell line expressing a Flag-epitope was used in these experiments. A total of 4g 
of cells were used to harvest total cell extracts in buffer A (20 mM Tris (pH7.5), 1mM DTT, 
10mM MgCl2 and 10%glycerol) containing 280mM NaCl using a combination of douncing and 
sonication for promoting lysis of the cells. The extract was dialyzed against Buffer A+280mM 
NaCl and passed through a 20ml DEAE cellulose column. The elution of proteins was monitored 
by measuring O.D.280 absorption and by Bradford assays (Biorad). The total protein (3mg) was 
concentrated using 0%–70% ammonium sulfate precipitation followed by elution through a 35 
ml S200-gel  ﬁltration  column.  The  protein  fraction  obtained  in  the  excluded  volume  was  loaded  
on a 15%–40% glycerol gradient (Buffer A+100mM NaCl) and centrifuged at 40,000 rpm for 
16hrs. The gradient was fractionated into approximately 500 ml fractions by inserting a needle at 
the bottom of the tube and collecting fractions drop wise. The peak fractions containing RNA 
exosome subunits (400 mg) were dialyzed against buffer A+100 mM NaCl. The sample was then 
immunoprecipitated with 100 ml of FLAG-agarose (Sigma) for 12 hr at 4°C (the FLAG-agarose 
slurry was pre-washed in PBS and equilibrated). The immunoprecipitate was washed with buffer 
A+200mM NaCl and eluted with 500ng of Flag peptide. For elution, the immunoprecipitate was 
incubated with the Flag peptide overnight at 4°C and then rotated on a nutator for 1 hr. The 
eluate was obtained by centrifuging the reaction and then isolating the supernatant separated 
from the beads. The elution step was repeated and the total eluate was dialyzed against Buffer 
A+50mM NaCl (containing 50% glycerol) and stored in small aliquots.  
 
2.5.5. Purification of AID Complex from Transcription-Coupled Deamination Assays 
 A total of 1.2 l of Ramos cells were grown in culture to a density of 1x106 cells/ml. These 
cells were harvested and total protein extract prepared as described (Chaudhuri et al., 2004; 
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Chaudhuri et al., 2003).  Brieﬂy,  we   re-suspended the cells in low salt buffer (20 mM Tris(pH 
7.5), 10 mM NaCl and 1 mM DTT). The cells were then incubated on ice for 20 min and lysed 
by douncing. The lysed cells were centrifuged and re-suspended in Buffer A + 280 mM NaCl 
ﬁrst   by sonication followed by douncing. The extract (approx. 0.15 g) was dialyzed against 
buffer A + 100 mM NaCl, centrifuged to remove debris and then incubated with 500 mg of T7-
RGYW (actively transcribed with 30,000U of T7 polymerase).The transcription reaction was 
incubated with cell extract for 30 min at 30°C and, thereafter, loaded onto a carboxy-methyl 
sepharose column (bed volume = 5 ml). Eluted fractions were analyzed for ability to deaminate a 
transcribed dsDNA substrate. The eluted proteins were then passed through a DEAE cellulose 
column  (A+280  mM  NaCl).  The  puriﬁed  fractions  were  dialyzed  against  buffer  A  +  25mM  NaCl  
and passed on a heparin-sepharose column (5 ml bed volume). For the heparin sepharose step, 
the column was equilibrated with buffer A+20 mM NaCl, washed with buffer A+50 mM NaCl 
and eluted with A+200mM NaCl. The eluted protein fractions were concentrated using 70% 
ammonium-sulfate precipitation (in cold with constant stirring and pH adjustment) and loaded on 
a 35ml S200 gel-ﬁltration  column. The protein fraction obtained in the exclusion volume was 
loaded on a 15%–40% glycerol gradient (containing buffer A+100mM NaCl) and fractionated at 
40,000 rpm for 16 hr. The fractions were collected by inserting a needle at the bottom of the tube 
and collected drop wise in 4°C. The fractions with highest transcription dependent cytidine DNA 
deamination activity were dialyzed against buffer A+100 mM NaCl. This preparation was 
immunoprecipitated with anti-AID antibodies for 8 hr at 4°C. The immunoprecipitated protein 
complex was eluted with AID specific peptide by incubating at 4°C overnight. The 
immunoprecipitate was centrifuged to remove the antibody bound beads and the supernatant 
collected for further work. The elution was repeated to avoid loss of sample. The components of 
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the eluate were separated via polyacrylamide gel electrophoresis (15% PAGE) and fragments of 
the gel were analyzed by mass spectrometry at the Rockefeller University Proteomics Research 
Center. For identification of the protein samples by mass spectrometry, the protein gel bands 
were excised from the 1D SDS-PAGE and were subject to in-gel reduction, alkylation, and 
trypsin-digestion. The digestion was performed for 16 hr at 37°C. The generated peptides were 
extracted with 50% acetonitrile and 0.1% TFA twice and dried on Speed-Vac. The dried peptides 
mixture was subject to LC/MS/MS analysis. For LC-MS/MS analysis, the peptide mixture was 
separated by a 60 min gradient elution with the Dionex U3000 capillary/nano-HPLC system 
(Dionex, Sunnyvale,  California)  at  a  ﬂow  rate  of  0.250  ml/min  that  is  directly  interfaced  with  the  
Thermo-Fisher LTQ-Orbitrap mass spectrometer (Thermo Fisher, San Jose, California) operated 
in data-dependent scan mode. The analytical column was a home-made fused silica capillary 
column (75 mm ID, 100 mm length; Upchurch, Oak Harbor, Washington) packed with C-18 
resin (300 A, 5 mm, Varian, Palo Alto, California). Mobile phase A consisted of 0.1% formic 
acid, and mobile phase B consisted of 100% acetonitrile and 0.1% formic acid. The 60 min 
gradients  at  0.250  ml/min  ﬂow  rate  for  B  solvent  went  from  0  to  55%  in  30  min  and  then  in  10  
min to 80%. The experiment consisted of a single full-scan mass spectrum in the Orbitrap (400-
1600 m/z, 30,000 resolution) followed by 6 independent MS/MS scans in the ion trap at 35% 
normalized collision energy. Data was analyzed by MASCOT software and manual inspection. 
 
2.5.6. Immunoprecipitation of AID/RNA Exosome Complex from Primary B Cells, 
CH12F3, Ramos Cells, and HEK293T Cells 
 Nuclear extracts from primary B cells and B cell lines were prepared as previously 
described (Chaudhuri et al., 2004; Chaudhuri et al., 2003). A 500 mg aliquot of extract was 
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treated with DEAE cellulose in a buffer containing 280 mM NaCl. The eluates were dialyzed 
against buffer A+100 mM NaCl and immunoprecipitated with anti-AID antibodies as described 
previously (Basu et al., 2005; Basu et al., 2008). Immunoprecipitates were washed with buffer 
A+150 mM NaCl and analyzed by SDS gel electrophoresis followed by Western blotting with 
anti-AID   antibodies   or   speciﬁc   antibodies   against   components   of   the  RNA  exosome   complex.  
The immunoprecipitation procedure was same as that for B cells except that immunoprecipitates 
were washed with buffer A + 400 mM NaCl.  
 
2.5.7. shRNA-Mediated Knockdown of RNA Exosome Components in CH12F3 Cell Lines 
 Human   ﬁbroblast   293   cells   were   co-transfected with lentiviral backdone plasmids and 
plasmids harboring shRNA against subunits of the RNA exosome complex (pLKO.1) using a 
calcium phosphate transfection protocol. Approximately 3 ml of viral supernatant from these 
transfected cells was overlayed on 3ml of CH12F3 cells in presence of 16 ug/ml polybrene. The 
cells were spin-infected for 90 minutes and then incubated at 37°C for 24 hr. Thereafter, the cells 
were selected in 0.5 ug/ml puromycin for 7 days followed by 1 mg/ml for 3–7 days. During the 
selection process the CH12F3 cells were grown in culture at dilutions of 1x104cells/ml media 




2.5.8. IgA CSR Analysis of CH12F3 Cells Depleted of Rrp40 and Mtr3  
 CH12F3 cells were analyzed for expression of surface IgA FITC-conjugated anti-mouse 
IgA clone (BD Biosciences), and APC-conjugated B220 antibodies (eBiosciences). The cells 
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were suspended in 2.5% FCS containing PBS, stained and washed with the same buffer before 
FACS analysis.  
 
2.5.9. Determination of Im and Ia Germline Transcription and Cell Growth of CH12F3 
Cells 
 Total RNA was extracted from cultured CH12F3 cells using Trizol (Invitrogen) 
according   to   the   manufacturer’s   instructions,   and   quantitated   by   measuring   A260   using   a  
Nanodrop spectrophotometer. 2 ug of RNA was treated with DNaseI (Invitrogen), immediately 
primed with oligo-dT and reverse transcribed using Superscript III Reverse Transcriptase 
(Invitrogen).   For   absolute   quantiﬁcation,   a   serial   dilution   of   control   sample   and   experimental  
sample  was  prepared  and  ampliﬁed  using  SYBR  Green  ROX  (Roche  Applied  Science),  using  the  
following primer pairs:  
  GLT  ImF  5’-CTCTGGCCCTGCTTATTGTTG-3’ 
  GLT  CmR  5’-GAAGACATTTGGGAAGGACTGACT-3’ 
  GLT  IaF  5’- CCTGGCTGTTCCCCTATGAA-3’ 
  GLT  CaR  5’-GAGCTGGTGGGAGTGTCAGTG-3’ 
  GAPDHF  5’-TGTCCCCACTGCCAACGTGTCA-3’ 
   GAPDHR  5’-AGCGTCAAAGGTGGAGGAGTGGGT-3’ 
 Real-Time PCR was performed using the ABI 7500 system (Applied Biosystems). 
Samples  were  cycled  followed  by  a  dissociation  stage.  Analysis  was  performed  using  the  ∆-∆CT  
method. The DNA synthesized was then quantitated using a Roche sybrgreen ROX kit and 
analyzed in a ABI real time PCR 7500 machine. The synthesized product was also estimated 
using 0.8% agarose gel electrophoresis. In some experiments, levels of Ia germline transcripts 
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were also determined by Northern blotting analyses as described (Nakamura et al., 1996). For 
analysis of cell growth of CH12F3 and RNA exosome subunit knockdown cell lines, the cells 
were harvested at respective time points from 15%FCS containing RPMI cultures. The cells were 
counted after trypan blue staining for estimation of live cell population. 
 
2.5.10. Chromatin Immunoprecipitation of Rrp40 from CH12F3 Cells and Primary Splenic 
B Cells  
 CH12F3 cells or primary spleen B cells were stimulated for IgA or IgG1 CSR for 48 hr. 
At this time point, the cells were treated with 1% formaldehyde in culture for 10 min followed by 
treatment with 0.125 M glycine to cross link the cellular DNA with bound proteins. The cross-
linked cells were then lysed in SDS lysis buffer and cell debris removed by passing the extract 
through glass wool. The extract was then precleared with ssDNA/Protein A agarose bead slurry 
in presence of non-speciﬁc  IgG  for  an  hour.  The  pre-cleared DNA was immunoprecipitated for 
Rrp40 using 1ug of anti-Rrp40 antibodies (Genway, rabbit polyclonal) or with control rabbit IgG 
for 8 hr at 4°C. These immuno-complexes were collected by adding ssDNA/protein A agarose by 
an incubation of 1hr at 4°C. The beads were isolated by centrifugation and sequentially washed 
with number of buffers. Each wash is for 5 min and repeated 3 times. The buffers used were (a) 
low salt buffer (b) high salt buffer (c) LiCl buffer and (d) TE. The immuno-complex was eluted 
in ChIP elution buffer. The eluted DNA was then prepared for further analysis by treatment with 
0.3M NaCl and RNase treatment. The DNA was cleaned of associated proteins by proteinase K 
treatment and extraction with phenol:chloroform:isoamyl alcohol. The extracted DNA was 
precipitated in presence of glycogen and washed with 70% ethanol and resuspended in water for 
further PCR analysis. The composition the buffers are as follows. (a) SDS lysis buffer: 1% SDS, 
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10 mM EDTA and 50 mM Tris pH 8.1 (b) ChIP dilution buffer: 0.01%SDS, 1.1% Triton X-100, 
1.2 mM EDTA, 16 mM Tris pH8.11 and 165 mM NaCl (c) Low salt and high salt wash buffers: 
0.1%SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris pH8.1, 150/500mM NaCl (d) LiCl wash 
buffer: 0.25M LiCl, 1% deoxycholic acid, 1%IGEPAL-CA630, 1mM EDTA and 10mM Tris 
pH8.1 (e) Elution buffer 1%SDS, 0.1M NaHCO3(Chaudhuri et al., 2003; Nambu et al., 2003). 
The  speciﬁc  primers  used  for  PCR  reactions  during  analysis  of  Sm  products  in  Rrp40 ChIP DNA 
are:  
  m-switch region-sense,  5’-TAGTAAGCGAGGCTCTAAAAAGCAT-3’ 
  m -switch region-antisense,  5’-AGAACAGTCCAGTGTAGGCAGTAGA-3’ 
  g1-switch region sense,  5’-TATGATGGAAAGAGGGTAGCATT-3’ 
  g1-switch region-antisense,  5’-CTGGGCTGGTCTGTCAACTCCTT-3’ 
  a-switch region-sense,  5’-TGAAAAGACTTTGGATGAAATGTGAACCAA-3’ 
  a-switch region-antisense,  5’-GATACTAGGTTGCATGGCTCCATTCACACA- 
   3’ 
  Real-Time PCR was performed using the ABI 7300 system (Applied Biosystems). 
Analysis   was   performed   using   the   ∆-∆CT   method.   The relative enrichment amounts were 
calculated by dividing DNA amounts from IP samples to Inputs (Appendix 7-2). Then, the fold 
changes were calculated by comparing stimulated versus un-stimulated CH12F3 cells and wild-
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3.1. Ubiquitin Proteasome System and Neddylation  
 The Ubiquitin-Proteasome system (UPS) regulates many cellular functions via targeted 
protein degradation. These functions include signal transduction pathways, DNA repair, histone 
modification, and cell cycle progression (Hershko and Ciechanover, 1992).  The UPS controls 
the selective and regulated degradation of more than 80% of cellular proteins (Crawford et al., 
2011).  Proteasomal degradation occurs in a multi-step process. First, a series of three enzymes 
(E1, E2, E3) links multiple ubiquitin molecules through lysine-48 residues, which are then 
conjugated to the target protein. This type of polyubiquitin chain marks the target protein for 
degradation by the 26s proteasome (Hershko and Ciechanover, 1992). Proteins are degraded by 
three major catalytic activities of the proteasome, which are determined by a preference to cleave 
after a particular amino acid residue (Heinemeyer et al., 2004). These catalytic activities include: 
chymotrypsin-like (CT-L), trypsin-like (T-L) and caspase like (C-L) (Heinemeyer et al., 2004).  
 
3.1.1. Neddylation, a Ubiquitin Like Modifier (UBL) 
  Protein modification by NEDD8,  an  event   termed  “neddylation,”   involves   the  covalent 
attachment of a small ubiquitin-like polypeptide to a target protein, with the help of E1, E2, and 
E3 neddylation ligases (See Figure 3-2 for a description of cellular neddylation pathway 
mechanism).  NEDD8 was originally identified using a subtractive hybridization approach of 
cDNA isolated from a mouse neural precursor cell (NPC) derived library. A set of clones, 
identified as NEDD, was isolated from the NPC library in which mRNA was predominantly 
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expressed in early embryonic brain and later developmentally down-regulated (Kumar et al., 
1992).  Further studies have identified Nedd8 as a conserved and essential gene across all 
eukaryotes, with the exception of the model-organism yeast, S. cerevisiae.  
Neddylation has been found to serve regulatory functions in various tissue types, 
including cell cycle control (Doronkin et al., 2003), transcriptional regulation (Xirodimas et al., 
2004), ribosomal protein stability (Xirodimas et al., 2008), regulation of hedgehog signaling (Du 
et al., 2011), and stimulation of ubiquitination reactions (Oved et al., 2006; Rabut and Peter, 
2008).  To this end, due to the various cellular functions of NEDD8, Rabut et al (Rabut and 
Peter, 2008) propose criteria for defining a genuine NEDD8 substrate protein: (A) Nedd8 must 
be covalently attached to the substrate, (B) Neddylation must occur under endogenous 
conditions, and (C) Neddylation must be dependent on components of the neddylation machinery 
in vivo.  
NEDD8, and its yeast homologue RUB1 (Hochstrasser, 1996; Liakopoulos et al., 1998), 
share nearly 60% sequence identity with ubiquitin (Kumar et al., 1992; Kumar et al., 1993; 
Liakopoulos et al., 1998). Conserved residues of ubiquitin and NEDD8 lie near a domain close to 
the C terminus of the protein, near which the substrate protein is conjugated (Liakopoulos et al., 
1998). Nedd8 is synthesized as a precursor peptide, requiring C terminal cleavage by 
isopeptidases to activate the protein for interaction with the E1 enzyme (Liakopoulos et al., 
1998). C terminal hydrolases include UCH-L3 (Yuh1p in yeast), a member of the UCH cysteine 
protease family which can also act on ubiquitin (Gan-Erdene et al., 2003; Linghu et al., 2002; 
Wada et al., 1998), and DEN1 (SENP8 or NEDP1 in yeast), a ULP family cysteine protease, 
which selectively binds Nedd8 (Gan-Erdene et al., 2003; Mendoza et al., 2003; Wu et al., 2003). 
C terminal cleavage to remove the terminal asparagine residue results in a mature form of the 
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protein of 76-amino acids, with a C-terminal di-glycine motif available for conjugation to 
substrate proteins (Liakopoulos et al., 1998).  
Activation of NEDD8 is mediated by a heterodimer of the E1 ligase, Appbp1/Uba3 
(UBA1/UBA3 in yeast) (Gong and Yeh, 1999; Liakopoulos et al., 1998). The UBA1 component 
of the E1 heterodimer contains a consensus sequence for nucleotide binding (ATP), 
GXGXXGCE (amino acids 475–482 in human UBE1) and an active site PZCTXXXXP 
surrounding the essential catalytic cysteine present in all E1 enzymes (amino acids 630–639 in 
human UBE1) (Gong and Yeh, 1999). Binding of the ubiquitin like protein (UBL), ATP, and 
Mg2+ to the E1 catalyzes adenylation of the C terminus of the UBL.  The catalytic cysteine of the 
E1 then attacks the UBL-adenylate and forms a covalent E1-UBL thiol ester intermediate 
(Huang et al., 2007). UBA3 has an almost identical nucleotide binding and active site motif 
(Gong and Yeh, 1999).  
Subsequent to E1-UBL intermediate formation, NEDD8 is transferred directly to an E2 
enzyme, generating an E2-UBL thiol ester product (Huang et al., 2007).  Before this transfer, the 
E1 will bind a second UBL molecule at the adenylation active site; therefore, one UBL is bound 
at  the  E1’s  catalytic  cysteine  (via  a  thiol  ester)  and  a  second  is  bound  at   the  adenylation  active  
site. To determine where the binding site for the E2 is located, a catalytically inactive E2 was 
used  to  create  and  crystallize  a  “trapped  activation  complex”  of  E1,  E2,  ATP,  and  Nedd8.  These  
studies revealed (Huang et al., 2007) that a rotation of the E1 ubiquition fold domain reveals a 
cryptic binding site for E2 recruitment, which allows the doubly UBL loaded E1 to bind the free 
E2.  At this point, the E1 will associate with the E2, and the UBL at the E1 catalytic cysteine will 
be transferred to the E2 catalytic cysteine by a transthiolation reaction (Huang et al., 2007). In 
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this manner, the E1 can act as a molecular switch to modulate binding affinities and drive the 
Nedd8 activating cycle (Huang et al., 2007).  
The E2 primarily associated with neddylation is UBE2M (UBC12 in yeast) (Huang et al., 
2005a; Liakopoulos et al., 1998; Osaka et al., 1998).  UBE2M has a 26-residue N-terminal 
extension upstream of the 150-residue conserved E2 core domain (Huang et al., 2004).  A 
deletion of the N terminal extension severely reduced the function of the protein in supporting 
thiol ester formation and transferring NEDD8 to substrate, as well as resulted in mitogenic 
defects (Huang et al., 2004). More extensive experiments on APPBP1-UBA3-UBE2M complex 
formation demonstrated that these defects were a result of the N terminal extension interacting 
selectively with the E1 to form a docking groove which maximizes enzyme efficiency(Huang et 
al., 2004). However, further studies demonstrated a bipartite interaction between the E1 and E2, 
where the E1 is also binding the E2 (Huang et al., 2005a).  Domain deletion studies of the E1 
revealed the E1 C terminal ubiquitin fold domain binds to the core domain of E2 (Huang et al., 
2005a). 
 UBE2M was accepted to be the dedicated E2 for neddylation (Huang et al., 2005a; 
Liakopoulos et al., 1998; Osaka et al., 1998). However, recent identification of a second E2 
specific for neddylation of certain cullins has been reported (Huang et al., 2009).  This E2, 
UBE2F, has a distinct function from UBE2M, as knock down of each protein in NIH 3T3 cells 
followed by Affymetrix gene chip microarrays revealed different gene expression profiles, with 
only 10% and 5% overlap for the up and down regulated genes, respectively (Huang et al., 
2009).  To identify direct targets of UBE2F, neddylation of individual cullin proteins was 
examined following UBE2F and UBE2M knockdown in NIH 3T3 cells.  Knockdown of UBE2F 
resulted in a decrease of neddylated Cul5, but had no effect on Culllins 1-4. However, 
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knockdown of UBE2M resulted in decreased levels of neddylated cullins 1-4 and a slight 
decrease in neddylated cul5.  These experiments show that different patterns of cullin 
neddylation are facilitated by two different E2 ligases (Huang et al., 2009).   
 Following association with the E2 enzyme, the E2-UBL complex becomes activated and 
associates with an E3 ligase, which facilitates transfer of the UBL to the target protein (Huang et 
al., 2007). There is structural overlap between the binding site on the E2 for the E1 and the E3 
enzyme; therefore, the E2 cannot bind both enzymes simultaneously (Huang et al., 2005a) which 
further underscores the regulation of binding affinities by the E1-E2   “switch” (Huang et al., 
2007).   
  The E3 then recruits the target protein and transfers the UBL from the E2 to a primary 
amino group on the target protein, often a lysine residue (Huang et al., 2004).  (see Figure 3-2 
for Mechanistic Overview). An isopeptide linkage is formed, occurring between the C-terminal 
glycine 76 of the UBL and the amino group of the target protein. There are two main classes of 
E3 ligases, the RING E3 ligases and the HECT domain E3 ligases, containing the RING or 
HECT E2 recognition domains, respectively. The type of E3 which is utilized in the UBL 
transfer determines the mechanism of UBL transfer to the substrate.  A RING  E3 ligase recruits 
the E2 through the RING domain and mediates transfer from the E2 to the substrate protein 
(Lorick et al., 1999).  A HECT domain E3 utitilizes a conserved catalytic cysteine to form a thiol 
ester linkage with the UBL, directly transferring the UBL from the E2 to the substrate protein 
(Huibregtse et al., 1995). E3 ligases are specific to the substrate protein, and are much less 
conserved than the E1 and E2 ligases (Chen, 2007).    
 The UBL can also be removed from the target protein by the actions of deconjugating 
enzymes, or isopeptidases. These enzymes are important for the regulation of the UBL (Chen, 
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2007).  The isopeptidases which function in the nedd8 cycle include USP21, CSN, and DEN1.  
USP21 belongs to the UBP/USP family of cysteine proteases, as it can act on both ubiquitin and 
Nedd8 substrates (Gong et al., 2000). CSN, or COP-9 signalosome, is a multisubunit complex 
which consists of 8 subunits (Chamovitz et al., 1996). The Csn5/Jab1 catalytic subunit of the 
CSN contains a JAMM metalloprotease domain which is responsible for the isopeptidase 
function of the CSN complex and is essential for the cleavage of Nedd8 from cullins (Cope et al., 
2002).  In addition to deconjugating NEDD8 from substrates, the isopeptidase DEN1 (NEDP1 in 
human) can also act on the precursor peptide of NEDD8 to expose the diglycine motif required 
for conjugation(Mendoza et al., 2003).  NEDP1 is specific for NEDD8 and cannot act on 
ubiquitin or SUMO-bearing carboxyl terminal extensions (Mendoza et al., 2003) and hydrolyzes 
extensions in a concentration dependent manner (Wu et al., 2003).  
 
3.1.2. Neddylation Substrates   
 The control of ubiquitination by NEDD8 is best understood in the cullin-RING family of 
E3 ligases (CRLs), which is also the best-characterized NEDD8 substrate group (see Table 3-1). 
The CRLs meet all criteria for characterization for NEDD8 substrates (Rabut and Peter, 2008). 
CRLs assemble together with another RING E3 ligase partner (Roc1-Rbx1), adaptors, and a 
substrate recognition protein. Once assembled together, these proteins form a molecular scaffold 
upon which substrate proteins can be recruited and polyubiquitin chains can be synthesized  
(Groisman et al., 2003; Pan et al., 2004) (Figure 3-1).  All CRLs, except APC2, are modified by 
the addition of NEDD8 to the C-terminus at a conserved lysine residue. NEDD8 modification 
regulates the function of the CRLs by inducing conformational changes within the ROC1-
Rbx1/CRL complex, stimulating ubiquitin-ligase activity (Pan et al., 2004).  
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 Several CRL ligases recognize substrates that regulate cell proliferation and survival, 
implicating CRLs in cancer development (Pan et al., 2004; Watson et al., 2011) (see Table 3-1). 
The CUL1 ligase complex  regulates  β-catenin and the inhibitory subunit of the pro-inflammatory 
transcription factor NF-Kβ  (IKβ).  Both  NF-Kβ  and  β-catenin have been implicated in cell cycle 
control and maintenance of ploidy (Nakayama et al., 2003), two properties important to the 
development of tumors.   CUL2 assembles into a scaffolding complex containing the von-
Hippel-Lindau (pVHL) tumor suppressor protein. This complex ubiquitinates and degrades 
HIF1-α,  which   transactivates  downstream  genes   involved   in   cancer.     Mutations   in  CUL2  have  
been found to contribute to colorectal cancers (Park et al., 2009).    NEDD8  acts  as  a  “molecular  
switch”   in   this   complex,   which   prevents   complete   formation   of   the   scaffold   when   VHL   is  
neddylated (Russell and Ohh, 2008). The CUL4A ligase complex has been shown to regulate 
genomic maintenance functions, such as nucleotide excision repair (NER) and transcription-
coupled DNA repair. In addition to CRL ligases, other NEDD8 substrates have been identified, 
including tumor suppressors of the p53 family and the oncoprotein MDM2, further implicating 
substrate regulation by neddylation in cancer development (Watson et al., 2011).  
 
Figure 3-1 (Adapted From Pan et al (Pan et al., 2004)): Cullin-Ring Ligase (CRL) Scaffold 
Assembly: Cullins act as scaffolding proteins, recruiting the ROC/Rbx1 RING E3 ligases and 
assembling a  site for substrate targeting. Neddylated cullin may assist to recruit the E2 and ubiquitin 
to transfer ubiquitin to the substrate.    
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Nedd8 Target  E3  Biological Role  
CUL1 Skp1, CUL1, F-Box, 
ROC1, Rbx1  
Cell cycle regulation 
Signal transduction 
Mouse Embryogenesis  
CUL2  Elongin B, Elongin 





 Regulation (VHL pathway)  
CUL3  BTB Protein, CUL3, 
ROC1/Rbx1  
S Phase Control 
Mouse embryogenesis 
Oxidative stress response  





DDB2 or CSA, 
ROC1/Rbx1  
Hematopoiesis  
Transcription coupled DNA Repair 
 Global genomic DNA repair 
 Mouse embryogenesis  
CUL5  Elongin B, Elongin 




mobilizing receptor signaling  
Assists E4orf6/E1B55K (p53 
degradation)  
Cul7  Skp1, CUL7, Fbx29, 
ROC1/Rbx1  
Mitosis Control 
Anti-apoptotic function (Regulates 
p53) 
Parc  Parc, Skp1  Inhibits p53 function (cytoplasmic 
sequestration) 
p53 MDM2 Regulates transactivation 
function/protein-protein interaction 
MDM2/L11 MDM2 Increases protein stability 
EGFR c-cbl Increases lysosomal sorting 
 
Table 3-1: Biological Roles of Nedd8 Targets: Adapted from Watson et al(Watson et al., 2011), Pan et 





3.1.3. Nedd8 and Cancer Therapeutics  
 To exploit CRL substrate regulation, a selective inhibitor of a component of the NEDD8 
pathway was designed via iterative medicinal chemistry (Soucy et al., 2009).  Specifically, the 
drug MLN4924 (Millennium Pharmaceuticals) interferes with the UPS-mediated degradation of 
a CUL4A substrate via inhibition of NEDD8 Activating Enzyme (NAE, see Figure 3-2 for 
pathway interaction). Increased DNA synthesis and resulting polyploidy in MLN4924 treated 
cells was discovered to be a result of deregulated turnover of CRL substrates in S phase.  Studies 
using RNA interference to knock down NAE in cancer cell lines resulted in similar defects 
(Milhollen et al., 2010; Soucy et al., 2009).  
 Preclinical data using mouse tumor xenografts demonstrated that MLN4924 treatment 
resulted in the inhibition of tumor growth (Soucy et al., 2009). Preclinical studies in diffuse large 
B cell lymphoma (DLBCL) have shown tumor regression in response to treatment with 
MLN4924 (Milhollen et al., 2010). These preclinical studies were used to guide dosing schedules 
for Phase I clinical trials. For instance, Millennium Pharmaceuticals is currently in Stage I of 
clinical trials using MLN4924 in the treatment of Acute Myeloid Leukemia.  Results of an open-
label, multi-center study were announced in December at an annual meeting of the American 
Society of Hematology (Ronan Swords, 2010). Results of the study included maximum tolerated 
dose and common side effects.  Notably, sixteen percent of patients achieved a complete 
response, warranting continuation of the study and further study of the efficacy of MLN4924 in 
the treatment of AML (Ronan Swords, 2006; Ronan Swords, 2010).  Clinical trials have also 
been initiated to investigate the efficacy of MLN4924 in nonhematologic malignancies 




Figure 3-2: Neddylation Cycle and MLN4924 Action: NEDD8 is synthesized as a precursor peptide 
with a C terminal tail, which must be cleaved by an isopeptidase.  The processed Nedd8 is activated by 
Nedd8 Activating Enzyme, also known as the E1, consisting of a heterodimer of Uba3 and Appbp1. 
Activation occurs in an ATP dependent manner, by forming a NEDD8-AMP intermediate and then 
transferring the NEDD8 to a cysteine residue on the E1 active site.  E2 loading occurs via NEDD8 
transfer from the E1 to the E2 conjugating enzyme Ubc12.  The E2 then interacts with an E3 ligase to 
mediate transfer to lysine residues on the substrate protein.  The E3 ligase can belong to one of two 
families, HECT or RING E3 ligases, depending on the type of ligase domain.  Unlike the E1 and E2 
enzymes, which are defined for the neddylation reaction, the E3 is unique to the substrate protein. 
NEDD8 may be cleaved from the substrate by a NEDD8 isopeptidase, releasing free NEDD8 available 
for use by the neddylation enzymes. The point of MLN4924 action is indicated on the figure.  MLN4924, 
an AMP analogue, binds to the AMP site in the E1 enzyme, forming a stable NEDD8-AMP adduct which 





3.2. Rationale of the Study  
 In Chapter II, we have identified the RNA Exosome as a necessary cofactor which targets 
AID to both strands of transcribed duplex DNA substrates in CSR. To facilitate AID activity on 
the template strand, RNA exosome must remove the template RNA. However, the mechanism by 
which the RNA exosome identifies the AID bound substrate and recognizes   the   3’-end of its 
RNA substrates remains unknown (Pavri and Nussenzweig, 2011). Here we seek to identify a 
factor   which   supports   generation   of   a   free   3’end   on   the   template   RNA,   thereby   providing   a  
substrate for RNA exosome and AID access to S region template strand.   
 
3.3. Experimental Design  
 To elucidate factors that might promote AID access to the template strand of transcribed 
substrates in the context of RNA/DNA hybrid structures, we in vitro transcribed an RGYW-rich 
dsDNA SHM substrate with T7 RNA polymerase in the presence of Ramos human B cell 
lymphoma line extracts.  Transcribed DNA-protein complexes were purified via 
chromatographic steps (Figure 2-2, Chapter 2) that would enrich for DNA binding (CM-
Sepharose, DEAE cellulose) and macromolecular complex formation (gel filtration 
chromatography), followed by heparin sepharose chromatography and anti-AID mediated 
affinity purification to enrich for complexes containing AID. Complexes were electrophoresed 
by SDS-PAGE and stained by Coomassie blue (Figure 2-2, Chapter 2).  Protein bands were 
isolated and identified by mass spectrometry analysis (Table 3-2, Appendix 7-3). In addition to 
components of the cellular RNA exosome (Chapter 2), we found components of the cellular 
neddylation pathway, Ubc12 and Appbp1/Uba3.   
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 We found that in these purification schemes, AID migrates as two polypeptides. Based on 
our observation that this purified complex consists of Neddylation enzymes E1 and E2; we 
investigated whether AID can be neddylated in B cells (Section 3.4). To this end, we found that 
B cell lines that had deficient amounts of RNA exosome, when treated with protein-
deneddylation inhibitors migrated with two polypeptides in vivo, with the higher polypeptide 
bands being a neddylated protein band. Based on these preliminary studies, we proposed to 
investigate whether AID interaction with cellular neddylation enzymes and subsequent AID 
modification is important during CSR.  
 
 
Table 3-2: Mass spectrometric  analyses  of  “AID  complex”  purified  from  B  cells. The components of 
cellular neddylation pathway are depicted along with number of peptides obtained and percent coverage 





3.4.1. AID Associates with Neddylation Complex Enzymes 
 To confirm that AID interacts with components of the neddylation pathway as identified 
in mass spectrometry analyses, we analyzed both endogenous and ectopically expressed AID.  
AID was immunoprecipitated from primary B cells stimulated in culture with anti-CD40 and 
IL4.  Immunoprecipitates were analyzed using antibodies to Ubc12 and AID to confirm 
interaction.  We then analyzed RNA exosome deficient B cell line CH12F3 stimulated for CSR 
to IgA (sh:Rrp40).  Subsets of sh:Rrp40 cells were treated with Nedd8-aldehyde, a specific 
inhibitor of Nedd8 isopeptidases, to enhance the accumulation of neddylated substrate 
molecules. We observed that in Nedd8-aldehyde-treated extracts obtained from sh:Rrp40 cells, 
AID migrated at two different polypeptide sizes in a 15% SDS-PAGE (Figure 3-3A). The size of 
this modified AID band was approximately 10kDa larger in size, consistent with Nedd8 
polypeptide size, suggesting a neddylated AID form. Strikingly, the level of neddylated AID is 
significantly higher in sh:Rrp40 conditions (Figures 3-3C & D).  Additionally, AID and His-6-
tagged Nedd8 were ectopically expressed in HEK293 cells. Immunoprecipitation with anti-AID 
antibodies followed by analysis by AID or Nedd8 specific antibodies indicates AID 
immunoprecipitates as a neddylated protein (Figure 3-3B).  Together, these analyses indicate 
that AID interacts with components of the neddylation pathway as well as the Nedd8 moiety in 
primary B cell lines, B cell lines, and when ectopically expressed in fibroblasts, confirming the 













Figure 3.3: AID is Neddylated in B Cell and Ectopically Expressed Fibroblast Cell Lines 
(A): Splenic B cells from wild-type (AID+/+) or AID-deficient (AID-/-) mice were stimulated in 
culture for induction of AID expression. AID immunoprecipitates using anti-AID antibodies 
were analyzed for presence of AID and Ubc12 via western blotting.  
(B): His6-NEDD8 was expressed alone or together with AID in HEK293 cells. 
Immunoprecipitation was performed with anti-AID antibodies and blotted for the presence AID 
(lower panel). The larger form of AID was shown to be immunoreactive to anti-NEDD8 
antibodies (top panel). 
(C) Quantification of CSR to IgA by flow cytometry in CH12F3 B-lineage cells transduced with 
lentivirus containing a scrambled short hairpin (sh) RNA (NS) or with shRNA against Rrp40 
(sh:Rrp40)   were   either   not   stimulated   (“un”)   or   stimulated   in   culture   for   two   days   with   anti-
CD40,  IL4,  and  TGFb  (“sti”)and  analyzed  for  CSR  to  IgA  by  flow cytometry and over multiple 
experiments (P<0.0001; n=4).  
(D) NS sti, and Rrp40 Sti total cell extracts were assayed for specific protein expression. Top 
panel demonstrates the level of Rrp40 expressed in these CH12F3 lines and bottom panel 





3.4.2. Neddylation Enzymes are Required for Optimal CSR 
 To evaluate AID as a potential substrate for neddylation, we evaluated the dependence of 
AID neddylation and the functional outcome of individually depleting each neddylation enzyme. 
To accomplish this depletion, a lentiviral shRNA knockdown system was utilized to introduce 
shRNA specific to one half of the E1 heterodimer, Appbp1, and the E2, Ubc12.  Stable cell lines 
were created which expressed reduced levels of Appbp1 or Ubc12 (Figure 3-4C). Cell growth 
and viability was analyzed by CFSE and trypan blue staining (Figure 3-4A, B), indicating a 
defect in sh:Ubc12 although no defects were observed in sh:Appbp1.   To evaluate the functional 
relevance of these enzymes on CSR, these lines were stimulated for CSR to IgA (Figure 3-4D).  
Evaluation by flow cytometry reveals a 20-50% reduction of WT levels in sh:Appbp1 lines, and 
a 30% reduction in sh:Ubc12 lines, indicating the necessity of these proteins for CSR.  
Strikingly, we observed a loss of Appbp1   leads   to   significant   stabilization   of   Sμ-germline 
transcripts (Figure 3-4E), providing evidence for the role of neddylation pathway components in 






Figure 3-4: Neddylation Pathway Enzymes E1 and E2 are required for CSR  
B-lineage cells CH12F3 infected with a scrambled short hairpin plasmid(NS) or with shRNA 
against  Appbp1  or  Ubc12  were  unstimulated  (“un”)  or  stimulated   in  culture  for   two  days  with  
anti-CD40, IL4, and  TGFb  (“st”).  For (A, C and D), the error bars represent standard deviation 
from mean of multiple sets of experiments. 
(A, B): Growth curve and viability of above described cell lines cells over a period of 72 hours 
as determined by trypan blue (A) and CFSE staining (B).  
(C): NS un, NS sti, sh:Appbp1(left), and sh:Ubc12(right) total cell extracts were assayed for 
specific protein and AID by western blotting.   
(D): CH12F3 NS, CH12F3shAppbp1 (left), and CH12Fsh:Ubc12 (right) were analyzed for CSR 
to IgA by flow cytometry (N=16; P=0.002-0.008).   
(E): Total RNA was isolated and analyzed for expression of Iu germline transcripts (Right) and 
Ia germline transcripts (left) using quantitative RT-PCR (N=3, P<0.0001Im; P=0.0434Ia).  
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3.4.3. Nedd4 Functions as E3 Ligase for AID Neddylation 
 To firmly establish AID as a substrate for Neddylation, we next sought to identify the 
unique E3 ligase for AID neddylation.  To accomplish this identification, we utilized a 
computational approach in which candidate proteins are screened based upon a repository of 
biological interactions and functional interactions created from millions of individually modeled 
relationships, substantiated from literature (Ingenuity Systems, IPA).  A panel of candidate E3 
ligases was selected based on the IPA screening criteria that AID specific E3 should interact with 
AID or AID structural and functional homologues. Based on our findings that exosome interacts 
with AID (Chapter 2), we postulated that neddylation pathway enzymes may interact with 
exosome or AID.  Although we did not find any previously known interactions with AID and 
neddylation E3 ligases, we found a direct interaction between Nedd4, a HECT-domain E3 ligase, 
and Apobec3G. Apobec3G is a DNA cytidine deaminase presumed to have arisen from a 
duplication of the AID gene during evolution (Conticello et al., 2007).  We generated an 
interaction map for AID structural and functional homologue Apobec3G and its interacting E3 
ligases (Figure 3-5A). Additionally, using this computational approach, we derived a putative 
E3 ligase map for neddylation pathway components and exosome interactions (Figure 3-5B). 
We generated individual shRNA knockdown lines (CH12F3) for each candidate E3 ligase. From 
Nedd4-deficient CH12F3 cells, CSR to IgA was compromised (data not shown, Figure 3-6A). 
Review of IPA interaction map using Nedd4 as candidate gene for interaction analysis reveals 
direct interactions with E2 ligases, as well as secondary interactions with AID structural and 












Figure 3-5: Screening and Identification of E3 Ligase Required for CSR 
(A): Interaction maps for Apobec3G and Nedd4. Note several interactions with E2 enzymes (purple). Key: tall 
diamond=enzyme; circle=complex; group, or other; square=cytokine; Triangle=phosphatase; oval=transcription 
regulator; flat diamond=peptidase.  
(B): Interaction map indicating Exosome components, Nedd8, and Neddylation Enzymes. Note interactions with 
Neddylation pathway components (red). Shape Key same as in A.  
 




3.4.4. Nedd4 is Required for Optimal CSR 
  To further pursue Nedd4 as a candidate neddylation E3 ligase specific for AID, we 
generated two independent shRNA knockdown lines of Nedd4 in CH12F3 B cell lines (Figure 
3.6A). We observed that CSR efficiency of Nedd4 depleted cells was 60-65% of wild-type levels 
(Figure 3-6A).  Analysis by CFSE and trypan blue staining reveal Nedd4 depletion does not 
significantly alter growth or proliferation (Figure 3-6B & C). Nedd4 knockdown cells had 
higher  levels  of  Iμ  and  Iα  transcripts  following  stimulation  (Figure 3-6D). Therefore, similar to 
E1 enzyme Appbp1, AID neddylation Nedd4 is required for normal CSR levels and generation 






Figure 3-6: Identification and Analysis of Nedd4 E3 Knockdown Cell Lines 
(A): (Left) Extensive IgA CSR flow cytometry analysis (representative results of N=9 experiments) of 
Nedd4 #433 shRNA expressing clone (sh:Nedd4:433). (Right) Total cellular extracts were isolated from 
sh:Nedd4:433 and analyzed for expression of Nedd4, AID, and actin (as loading control). Results are 
representative of three independent sets of three experiments 
(B): Trypan Blue and (C): CFSE proliferation analysis and growth curves of stimulated sh:Nedd4:433 
CH12F3 cells calculated from three independent sets of three experiments. Values represent average and 
standard deviation from the mean.   
(D): Total cellular RNA from three independently stimulated samples of indicated CH12F3 isolates was 
assayed   for   Iμ   transcripts   (top)   and   Iα   transcripts   (bottom)   via   quantitative   RT-PCR.  Average and 
standard deviation from the mean is shown for the three separate experiments. 
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3.4.5. Association of Neddylation Enzymes and Exosome Subunits with S Regions in B 
Cells activated for CSR 
 To evaluate putative function of Neddylation enzymes as AID targeting factors, we 
evaluated their potential to associate with subunits of the RNA exosome complex (Rrp40) or 
exosome associated factors (Spt5). AID was immunoprecipitated from Neddylation enzyme 
deficient cells stimulated with anti-CD40, IL-4 and TGF-β to induce CSR to IgA (sh:Appbp1, 
sh:Ubc12, or sh:Nedd4). Immunoprecipitates were analyzed to determine the in vivo association 
between AID and RNA exosome subunits or associated components. Immunoprecipitates were 
analyzed by western blotting with specific antibodies AID, Rrp40, or Spt5.  These analyses 
revealed that AID strongly associated with Rrp40 and Spt5 in wild type cells stimulated for CSR; 
however, a weaker association was detected in neddylation enzyme deficient cells (Figure 3-7A, 
3-7B). Together, these analyses demonstrate an association in vivo of AID, neddylation 
enzymes, and RNA exosome, either directly or indirectly. 
 Additionally, to evaluate putative function of Neddylation enzymes as AID targeting 
factors, we evaluated the potential to associate with transcribed S regions in activated B cells. 
We performed chromatin immunoprecipitation to test whether Rrp40 or AID associates with 
transcribed S regions in activated CH12F3 or CH12F3 deficient in neddylation 
enzymes(sh:Appbp1, sh:Ubc12, or sh:Nedd4), before and after stimulation for CSR to IgA. 
Immunoprecipitates were processed for isolation of bound DNA. We performed quantitative 
PCR  to  determine  levels  of  Rrp40  or  AID  bound  to  Sμ (Figure 3-7C).  Analyses of these regions 
revealed  enrichment  of  Sμ  in  the  anti-Rrp40 chromatin immunoprecipitates from stimulated cells 
as compared to unstimulated cells. Markedly, Rrp40 or AID  recruitment  was  not  detected  at  Sμ  
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regions in Appbp1, Ubc12, or Nedd4 deficient cells, indicating that the RNA exosome complex 








Figure 3-7: Neddylation Enzymes E1, E2, E3 are required for AID or Rrp40 interaction and  
recruitment to switch regions. CH12F3  cells  were  either  stimulated  (“St”  or  “S”)  with  TGFβ,  IL4,  and  
CD40  or  kept  unstimulated  (“Un”  or  “U”) for 48hr.   
 (A): AID immunoprecipitates from extracts of CSR-activated CH12F3 wild type or shRNA depleted 
neddylation component cells were assayed for Rrp40, Spt5, and AID (indicated on the right) via western 
blotting.  The right two lanes show western blotting of total extract (Input), and the right two lanes show 
western blotting of immunoprecipitated products.   
 (B): AID immunoprecipitates from extracts of CSR-activated CH12F3 wild type or sh:Nedd4 cells were 
assayed for Rrp40, Spt5, and AID (indicated on the right) via western blotting.  The right two lanes show 
western blotting of total extract (Input), and the right two lanes show western blotting of 
immunoprecipitated products.   
(C): Rrp40 or AID was immunoprecipitated from cell extracts under chromatin immunoprecipitation 
conditions (ChIP). The ChIPed Ab-DNA complex from CH12F3 cells was processed to isolate bound 
DNA.      ChIPed   DNA   was   tested   for   Sμ   sequences   via   q-PCR. The q-PCR product was analyzed by 
agarose gel electrophoresis in triplicate.  
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3.4.6. Nedd4 Modifies AID at Residues K10 and K16 
 
 To ascertain that Nedd4 can catalyze AID neddylation, we obtained recombinant Nedd8 
conjugate and E1/ E2 enzymes, and we assayed for neddylation in the presence of purified AID 
the presence of one of two isoforms of Nedd4.  Nedd4-1 and Nedd4-2 HA-epitope tagged Nedd4 
isoforms were obtained from HEK293 cells following expression and partial purification. We 
observed that AID exists as a single polypeptide protein in the absence of neddylation, following 
purification and coomassie staining (Figure 3-8A Left).  However, when neddylated in the 
presence of E1, E2, and purified HA-Nedd4-1293 , the AID protein migrated in multiple bands 
with approximately 19kDa increment in size (Figure 3-8A Left). When probed with anti-Nedd8 
antibodies, these modified forms of AID reactive, suggesting a neddylation modification. Mass 
spectrometric analysis of this in vitro neddylated protein (Figure 3-8B Left) revealed that the 
primary addition site is the lysine-10 residue of AID protein (Figure 3-8B Right). Based on the 
spectral analysis of neddylated AID protein, we postulate due to localization of lysine-16 within 
the AID lysine-10 tryptic peptide, lysine-16 could be a secondary site.  From these observations, 
we conclude that Nedd4 mediates AID neddylation, and this modification occurs on residues 







Figure 3-8: Nedd4 E3 Ligase Mediates Neddylation in vitro 
(A): (Left) Recombinant E1, E2, and immunoprecipitated NEDD4-1 were combined in the 
presence or absence of recombinant AID under conditions of in vitro neddylation. * represents 
an aspecific band that is recognized by the anti-AID and the anti-Neddylation antibodies and is 
contributed by the E1, E2 and E3 reaction mixture.  (Right, Upper) Catalytically active form of 
NEDD4 was immunoprecipitated from HA-NEDD4 expressing 293T cells using HA affinity gel 
followed by HA peptide challenge.  (Right, Lower)  Recombinant E1 and E2were combined in 
the presence or absence of recombinant AID under conditions of in vitro neddylation to 
demonstrate aspecific band that is recognized by the anti-AID and the anti-Neddylation 
antibodies and is contributed by the E1, E2 reaction mixture. 
(B):   (Left) In vitro neddylated recombinant AID was analyzed by coomassie staining 
following 15% SDS-PAGE. The content of the complex was determined by mass spectrometric 
analysis. (right) Following SDS-PAGE separation, proteins obtained were enzymatically-
digested using trypsin to obtain tryptic peptides, which were subsequently characterized by LC-
MS/MS. The MS/MS spectrum of a doubly charged ion at m/z 544.34 for MH22+ 
corresponding to the mass of the neddylated peptide KFLYQFK. The labeled peaks correspond 
to masses of b and y ions of unmodified peptides and ubiquitinated peptides. The additions of 
114 Dalton (mass of GlyGly) were observed for b2, thus demonstrating that neddylation was on 
Lys10 residue containing peptide. 
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 For further analysis of the specific site of neddylation on AID, as well as the functional 
outcome, we assayed the ability of AIDWT, AIDK10A, AIDK16A, and AIDK10AK16A to catalyze CSR 
and SHM.  CSR analysis was performed in AID deficient primary B cells ex vivo retrovirally 
complemented with the indicated mutant AID constructs and analyzed for CSR to IgG1. We 
observed that AID mutants that are lacking either K10 or K16 have reduced CSR; 
AIDK10AK16A manifests even stronger defects (Figure 3-9A). To rule out defects in protein 
expression due to mutations, protein extracts were prepared and analyzed by western blotting.  
These analyses determined that these mutant AID proteins expressed at similar levels in B cells. 
In vitro ssDNA SHM analysis was performed using T7 SHM assay as previously described 
(Chaudhuri et al., 2003) using AIDWT or mutant forms of AID transfected into HEK293 cells in 
the presence or absence of overexpressed His-6-Nedd8 (Figure 3-9B).  In vitro ssDNA SHM 
analysis was inconclusive in single mutant analysis, but reveals a modest decrease in 
deamination upon mutation of both K10 and K16. Together, both analyses support modification 
as occurring on residues K10 and K16, and these modifications are functionally relevant for the 










Figure 3-9: AID-neddylation sites Lysine 10 and 16 are required for efficient CSR in 
Mouse B cells.  
(A): (left)AID-deficient splenic B cells stimulated with anti-CD40 and IL-4 were infected with a 
retrovirus expressing either wild-type AID, AIDK10A, AIDK16A, or AIDK10AK16A ; the level of CSR 
to IgG1 catalyzed by these AID proteins was evaluated using flow cytometry. (right) Total cell 
extracts were blotted with anti-AID antibodies and anti-GFP antibodies. Anti-tubulin was used 
as loading control. 
(B): AIDWT or AID mutants were transfected into HEK293 fibroblast cells and assayed for 
cytidine deamination in the presence or absence of His6-Nedd8.  
(C): (left) AID deficient primary B cells were infected with AIDWT or AIDK10AK16A mutant in 
presence or absence of deneddylation inhibitor 8-aldehyde-NEDD8. Total cell extracts were 
prepared from these retrovirally transduced cells and immunoprecipitated with NEDD8 
conjugated agarose. (right)  Immunoprecipitates were analyzed by western blotting with anti-




 To unequivocally demonstrate that these residues are modified in B cells, we transfected 
AIDWT or AIDK10AK16A in the presence or absence of Nedd8 and demonstrated that unlike 
AIDWT, mutant AIDK10AK16A was not Nedd8 modified (Figure 3-9C, Left). To determine if AID 
is neddylated at K10 and K16 in B cells, we introduced AIDWT and AIDK10AK16A in AID-
deficient primary B cells and treated the cells with increasing concentrations of deneddylation 
inhibitor Nedd8-aldehyde. These experiments demonstrated that in AID-deficient primary B 
cells, retroviral introduction of AID followed by Nedd8-aldehyde treatment led to the expression 
of two forms of the AID polypeptide.  One form of AID migrated at a higher molecular weight, 
consistent with a 10kDa modification such as neddylation would provide. This form was 
sensitive to the integrity of the K10 and K16 residues (Figure 3-9C, Left).  
 Additionally, using these retroviral transduced B cells, we immunoprecipitated total 
cellular Nedd8-conjugated proteins.  Western blotting analysis with Nedd8 and AID antibodies 
revealed that AIDWT immunoprecipitated as a neddylated protein, whereas AIDK10AK16A did not 
(Figure 3-9C, Right). The efficiency of AID immunoprecipitated increased following treatment 
with Nedd8-aldehyde. When probed with antibody specific to exosome subunit Rrp40, we 
observed strong binding to AIDWT immunoprecipitates but reduced binding in AIDK10AK16A 
immunoprecipitates.  These immunoprecipitation experiments indicate not only is AID 
neddylated in B cells, but also the integrity of the K10 and K16 residues is important for 







3.4.7. Nedd4 Functions as a Neddylation and Ubiquitin E3 Ligase 
 Previous studies have characterized Nedd4 as an E3 ubiquitin ligase of transcriptionally 
stalled RNA polymerase II, targeting the stalled polymerase for proteasomal degradation 
(Anindya et al., 2007). As we have found that Nedd4 is a component of the AID bound 
transcriptional complex, we investigated whether RNA polymerase II ubiquitination is Nedd4 
dependent, and whether this modification determines its accumulation kinetics in transcribed 
IgSμ  regions.  We  stimulated  CH12F3:sh:Nedd4 or CH12F3 with a nonspecific shRNA (NS) for 
IgA CSR for 48 hours. Western blotting was performed to verify that levels of RNA polymerase 
(subunit 4H8 specific antibody) and AID were unaltered by Nedd4 knockdown (Figure 3-10A 
Left). Directed chromatin immunoprecipitation was performed to assess RNA polymerase 
recruitment to IgSμ region. By these chromatin immunoprecipitation assays, we have found cells 
reduced in Nedd4 expression show a striking increase in RNA polymerase recruitment at the 
IgSμ  region (Figure 3-10B). We next isolated total cellular ubiquitinated proteins by ubiquitin 
affinity purification from sh:Nedd4 and wild type cells.  Proteasome inhibitor MG132 was added 
at a low concentration for duration of CSR stimulation, and at a higher concentration one hour 
before protein extraction to minimize ubiquitin-mediated proteasomal degradation. Under these 
conditions, Nedd4 knockdown manifests a deficient of total ubiquitinated RNA polymerase II 
(Figure 3-10A, Right). Under these conditions, the level of AID ubiquitination level or PCNA 
ubiquitination levels remained relatively unaltered (Figure 3-10A, Right). Together, these 
experiments implicate a role for Nedd4 in the ubiquitin-mediated turnover of RNA polymerase 








Figure 3-10: NEDD4 ubiquitinates RNA polymerase II and regulates its stability on the Ig-
switch regions in a B cell line  
(A): (left)The levels of AID and RNA polII subunit (RPB1) in NS and NEDD4-deficient cells 
were analyzed by direct western blotting. (right) NS un, NS sti, and sh:NEDD4-1 were 
unstimulated or stimulated in culture for two days in the presence of proteasome inhibitor 
MG132. Nuclear extracts were prepared and total ubiquitinated proteins were captured using 
ubiquitin affinity resin.  Immunoprecipitates were analyzed using anti-RPBI 4H8 antibody to 
analyze ubiquitinated RNAPII or anti-AID to analyze ubiquitinated AID.  Total extracts were 
analyzed with antibodies to RPBI, AID, and actin was used as loading control (shown in A).   
(B): RNA polymerase subunit RPBI (4H8) was immunoprecipitated under conditions of 
chromatin immunoprecipitation from cell lines used in (A).  The RPBI-DNA complex was 







  We next sought to confirm the role of Nedd4 in primary B cells; however, Nedd4 
knockout presents as embryonic lethal in mice (Yang et al., 2008). Therefore, to circumvent this 
problem, we obtained Nedd4-deficient mouse spleens from fetal liver Nedd4 -/- chimeras 
(Figure 3-11A Left), and we purified B cells from these spleens. Nedd4 -/- and +/+ cells 
proliferated similarly as determined by trypan blue staining (Figure 3-11A Right). Primary 
splenic B cells were stimulated in culture with anti-CD40 and IL4 to induce CSR to IgG1. 
Analysis of CSR revealed that Nedd4 -/- cells were deficient in CSR, as compared to Nedd4 +/+ 
cells (Figure 3-11B).  Ubiquitin affinity purification reveals these cells also have decreased 
levels of ubiquitinated RNA polymerase II but not other cellular proteins (PCNA), similar to 
Nedd4 deficient CH12 cell lines (Figure 3-11C, Left). Steady state germline transcript levels 
were   increased   from   the   IgSγ   locus (Figure 3-11C, Right).  Collectively, these observations 
provide evidence that Nedd4 ubiquitinates RNA polymerase II to initiate its turnover in B cells. 
In Nedd4 deficient cells, there  is  an  increase  in  IgSγ-bound RNA polymerase II steady state level 
that  potentially  prevents   the  Sγ-germline   transcript   from  being  detached   at   its   3’-end from the 











Figure 3-11: NEDD4 ubiquitinates RNA polymerase II and regulates its stability on the Ig-
switch regions in primary B cells 
(A): Genotype strategy and results of Nedd4 +/+ and -/- fetal liver chimeras (Left). Primary 
splenic B cells were prepared and stimulated in culture for 72 hours with anti-CD40 and IL4 to 
induce CSR to IgG1. Cell proliferation was determined by trypan blue staining (Right)  
(B): Nedd4 +/+ and -/- primary splenic B cells stimulated in culture for 72 hours with anti-CD40 
and IL4 were evaluated for CSR to IgG1 by flow cytometry (left) Representative FACS plot 
(right) quantitation of N=4 pairs 
(C): (right) Nuclear extracts were prepared and total ubiquitinated proteins were captured using 
ubiquitin affinity resin.  Immunoprecipitates were analyzed using anti-RPBI 4H8 antibody to 
analyze ubiquitinated RNAPII or anti-AID to analyze ubiquitinated AID.  (Left) Total cellular 
RNA from three independently stimulated samples of indicated splenic B cell isolates was 





3.5. Materials and Methods 
 
3.5.1. Antibodies and Plasmids 
  AID antibodies were generated as described (Chaudhuri et al., 2003). Anti-exosome 
subunit antibodies were purchased from Genway or Abcam.  Anti-neddylation antibodies were 
purchased from Boston Biochemical or Rockland. Nedd8 (Alexis); APPBP1 (Boston Biochem); 
Ubc12 (Rockland); Nedd4; Rnf8, Tubulin (Abcam); Actin, Flag (Sigma); RNAPolII (4H8, 
Abcam). All secondary HRP-conjugated antibodies were from Sigma. 
 
3.5.2. CSR analysis of Exosome component or Neddylation component deficient CH12F3 
cells  
 We performed shRNA-mediated knockdowns in CH12F3 cells according to TRC shRNA 
library protocols.  Knockdown efficiencies were determined by western blotting using specific 
antibodies to the knockdown protein.  CSR was determined by using a BD LSRII flow cytometer 
to analyze surface levels of IgA on B220+ cells. Germline S region transcript levels were 
performed according to published protocols (Muramatsu et al., 2000). 
 
3.5.3. Lentiviral Knock Down Assay  
 Human fibroblast 293T cells were co-transfected with lentiviral backbone plasmids and 
plasmids pLKO-1 containing shRNA directed against components of the neddylation cycle, 
using calcium phosphate method.  Approximately 3mL of supernatant collected from the 
transfected cells was overlayed on CH12F3 cells plated at a density of 0.25million cells/mL.  
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The cultures were supplemented with 16ug/mL polybrene and centrifuged at 2500rpm for 
90minutes for infection, followed by incubation in 37°C CO2 humidified incubator for 24hr.  
Virus and polybrene containing media were removed, and the cells were selected with 0.5ug/ml 
puromycin for 2-7 days.  The sequences of shRNAs directed against neddylation cycle 














3.5.4. IgA CSR Analysis of Neddylation Cycle Depleted Components  
 CH12F3 cells were analyzed for the expression of surface IgA using FITC conjugated 
anti-mouse IgA  (BDBiosciences) and APC conjugated B220 (eBiosciences). The cells were 




3.5.5. Iμ and Iγ transcript determination and cell growth curves 
  Total RNA was extracted from cultured CH12F3-2 cells using Trizol (Invitrogen, 
Carlsbad  CA)  according   to   the  manufacturer’s   instructions,   and  quantitated  by  measuring  A260 
using a Nanodrop spectrophotometer. 2ug of RNA was treated with DNAseI (Invitrogen, 
Carlsbad CA), immediately primed with oligo-dt(20), and reverse transcribed using Superscript 
III Reverse Transcriptase (Invitrogen, Carlsbad CA). 
 For absolute quantification, a serial dilution of control sample and experimental sample 
was prepared and amplified using SYBR Green ROX (Roche Applied Science, Indianapolis IN), 
using the following primer pairs:  
 GLT ImF  5’-CTCTGGCCCTGCTTATTGTTG-3’ 
 GLT CmR 5’-GAAGACATTTGGGAAGGACTGACT-3’ 
 GLT IaF 5’- CCTGGCTGTTCCCCTATGAA-3’ 
 GLT CaR  5’-GAGCTGGTGGGAGTGTCAGTG-3’ 
 GAPDHF 5′-TGTCCCCACTGCCAACGTGTCA-3′ 
 GAPDHR 5′-AGCGTCAAAGGTGGAGGAGTGGGT-3′.  
  
 Real-Time PCR was performed using the Eppendorph Realplex2.  Samples were cycled 
followed   by   a   dissociation   stage.      Analysis   was   performed   using   the   ∆-∆CT  method.  Where  
indicated, cells were treated with 0.25uM MG132 (Sigma) at time of plating, plus 10uM 1hr 
before extraction. For analysis of cell growth curves, the cells were plated at starting dilution of 
1x104 or 5x104 cells/mL. Samples were removed at respective time points from 15%RPMI media 




3.5.6. Immunoprecipitation of AID and Neddylation Complex from 293T and CH12F3 
Cells  
 We used previously described protocols to immunoprecipitate the AID complex from B 
cells or 293T cells (Chaudhuri et al., 2004; Chaudhuri et al., 2003). When indicated total cellular 
extracts were prepared using RIPA lysis buffer for either CH12F3 or 293T cells. Nuclear extracts 
from CH12F3 B cells and 293T fibroblasts were prepared as described (Chaudhuri et al., 2004; 
Chaudhuri et al., 2003). A 250ug aliquot of extract was treated with DEAE cellulose in a buffer 
containing 280mM NaCl. Total cellular extracts were prepared by washing CH12F3 B cells or 
293T fibroblasts in PBS followed by lysis in RIPA buffer prepared in the presence of protease 
inhibitor (Roche).    Nuclear or total extracts were immunoprecipitated with antibodies to AID 
using either protein A agarose (Sigma) or Nedd8-conjugated agarose (Boston Biochemical).  
Immunoprecipitates were washed with PBS containing 100mM NaCl and analyzed by SDS gel 
electrophoresis followed by western blotting with anti-AID antibodies or specific antibodies to 
components of the neddylation cycle. For interaction studies in 293T cells, each individual Flag-
tagged exosome subunit plus AID or mutant AID were co-expressed with His-tagged Nedd8 
(obtained from D. Xirodimas, U. of Dundee) following transfection using calcium phosphate into 
293T fibroblast cells and harvested for total cellular extracts 48hr later.  Immunoprecipitation 
reactions using anti-AID antibodies were performed as above and analyzed using SDS gel 
electrophoresis following western blotting with anti-AID or anti-flag antibodies. 
 
3.5.7. Retroviral Production, Splenic B cell isolation, and B cell infection 
  AID was expressed in pcDNA as previously described (Chaudhuri et al., 2004; 
Chaudhuri et al., 2003). AID mutants (AIDK10A, AIDK16A, AIDK10AK16A) were generated by 
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mutation of the AID open reading frame cloned into pcDNA using site directed mutagenesis 
PCR (PfuTurbo, Stratagene). The mutant AID open reading frame was subcloned into pMXPIE 
vector containing IRES-GFP as previously described(Fagarasan et al., 2001).  The plasmid was 
transfected using calcium phosphate method into Phoenix E cells (Orbigen) for viral packaging.  
Virus was overlayed on anti-CD40, Il-4 pre-activated splenic B cells harvested from AID 
deficient mice by CD43 negative selection (Militenyi columns).  The cultures were 
supplemented with 16 ug/ml polybrene and centrifuged at 2500rpm for 90 minutes for infection, 
followed by incubation in 37°C CO2 humidified incubator for 48hr.  Cells were assayed for 
surface IgG1 production (BD Biosciences) and presence of GFP as indication of retroviral 
infection. Cells were cultured in RPMI supplemented with 15% serum and 50uM β-
mercaptoethanol (15%RPMI). Protein extracts were prepared by addition of RIPA for total 
protein extraction. 
 
3.5.8. Immunoprecipitation of NEDD4 
  For immunoprecipitation of HA-Nedd4 and HA-Nedd4-2, pcDNA-HA-NEDD4 and 
pcDNA-HA-NEDD4-2, constructs (obtained from W. Yang, Geisinger Clinic, Danville) were 
transfected into 293T cells.  Nuclear extracts were prepared by douncing in low salt buffer 
(10mM Tris-HCl pH 7.5, 10mM NaCl, 1mM DTT), followed by addition of 2X high salt buffer 
(40mM Tris-HCl, pH 7.5, 1mM EDTA, 1.2M NaCl, 2mM DTT, 20uM ZnCl2, 2% NP40, 
protease inhibitor, Roche).  Extracts were centrifuged at high speed and supernatants were 
dialyzed for against buffer A + 280mM NaCl (20mM Tris-HCl pH 7.5, 0.5mM EDTA, 1mM 
DTT, 5% Glycerol, 10uM ZnCl2), followed by incubation with DEAE cellulose resin.  Extracts 
were again centrifuged to remove resin, and supernatants were dialyzed against buffer A+ 
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100mM NaCl.  Protein concentration was measured using Bradford assay and 
immunoprecipitated using EZ-view HA affinity gel (Sigma) overnight.  Immunoprecipitates 
were washed with PBS + 100mM NaCl three times, followed by the addition of Buffer A + 
100mM and HA peptide (100ug/ml) overnight.  Samples were centrifuged and supernatant 
containing immunoprecipitated NEDD4 was used for in vitro neddylation experiments or other 
purposes. 
 
3.5.9. Ubiquitin Immunoprecipitation  
 Protein extracts were prepared as above using a combination of low salt/2X high salt 
buffer extraction.  Where indicated, cells were treated with 0.25uM MG132 (Sigma) at time of 
plating, plus 10uM 1hr before extraction.  Extracts were diluted 50% in TBS plus polyubiquitin 
affinity resin and incubated overnight in manufacturer provided spin columns (Thermo 
Scientific).  Samples were washed in a 1:9 wash buffer of lysis buffer:TBS three times followed 
by addition of 4X Lamelli buffer directly to column.  Columns were boiled followed by 
centrifugation to collect ubiquitin-enriched fractions. Samples were analyzed by 15% SDS-
PAGE followed by western blotting for indicated proteins. 
 
3.5.10. In Vitro Neddylation 
  For in vitro NEDD8 modification of AID, APPBP1/Uba3 (0.5ug, Boston Biochem), 
Ubc12 (0.5ug, Boston Biochem), NEDD8 (3ug, Boston Biochem), AID (10ug), and 
immunoprecipitated HA-NEDD4 are mixed in a final volume of 40ul (20mM Tris-HCl, pH 7.5, 
2mM ATP, 1mM DTT, 1uM CaCl2). Reactions are incubated for 30 minutes at 30°C before 
termination by addition of 3X Lamelli buffer.  Samples are boiled and analyzed by 12% SDS-
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PAGE followed by western blotting for AID or NEDD8.  For mass spectroscopic analysis, the in 
vitro modified AID sample was separated by 12% SDS-PAGE. The gel bands corresponding to 
the targeted protein were excised from the gel, reduced with 10 mM of DTT and alkylated 
with 55 mM iodoacetamide. Then in gel digestion was carried out with the sequence grade 
modified trypsin (Promega, Fitchburg, WI) in 50 mM ammonium bicarbonate at 37 °C 
overnight. The peptides were extracted twice with 1% trifluoroacetic acid in 50% acetonitrile 
aqueous solution for 30 min. The extractions were then centrifuged in a speedvac to reduce the 
volume. 
 
3.5.11.  Mass Spectrometric Analysis 
 For LC-MS/MS analysis, the digestion product was separated by a 65 min gradient 
elution at a flow rate 0.250 uL/min with the EASY-nLCII™   integrated   nano-HPLC system 
(Proxeon, Denmark) that is directly interfaced with the Thermo LTQ-Orbitrap mass 
spectrometer. The analytical column was a home-made fused silica capillary column (75 um ID, 
150 mm length; Upchurch, Oak Harbor, WA) packed with C-18 resin (300 A, 5 um, Varian, 
Lexington, MA). Mobile phase A consisted of 0.1% formic acid, and mobile phase B consisted 
of 100% acetonitrile and 0.1% formic acid. The LTQ-Orbitrap mass spectrometer was operated 
in the data-dependent acquisition mode using the Xcalibur 2.0.7 software and there is a single 
full-scan mass spectrum in the Orbitrap (400-1800 m/z, 30,000 resolution) followed by 6 data-
dependent MS/MS scans in the ion trap at 35% normalized collision energy. The MS/MS spectra 
from each LC-MS/MS run were searched against the selected database using an in-house Mascot 




3.5.12. CFSE Staining 
  CH12F3WT or shCH12F3 lines were labeled at a density of 0.5x106 ml-1. CFSE was 
diluted directly into the cell suspension at a final volume of 5uM.  CFSE labeling was performed 
for 5 minutes at room temperature before extensive washing with 5%FCS to remove 
unincorporated CFSE.  Labeled cells were plated at a density of 5x104 ml-1. After 5 hours, 
aliquots were removed and analyzed by FACS (0 HR time point).  Remaining cells were 
stimulated for CSR using anti-CD40, IL-4 and TGF-β.   Aliquots   of   stimulated   cells   were  
removed at appropriate time points (24, 28, 72 HR) for FACS analysis.  
 
3.5.13. NEDD4-deficent fetal liver chimeras  
 The generation of Nedd4+/+ and Nedd4-/- fetal liver chimeras was previously described 
(Yang et al., 2008). Briefly, fetal livers were collected at day 14-16 p.c.. Fetal liver cells were 
transferred into lethally irradiated Rag1-/- recipients by i.v. injection. Spleens were isolated 6-8 








4. Discussion  
4.1. Transcription Targets AID to S regions 
 B cells express optimal amounts of AID mRNA and protein by IL-4 and CD40 signaling 
via induction of Stat6 and NF-kB transcription factors (Dedeoglu et al., 2004). Additional 
cytokines produced by T helper and dendritic cells induce transcription from germline promoters 
located  5’  to  each  acceptor S region, which determine the isotype of the resulting switched B cell 
(Jung et al., 1993).  It has been suggested that the function of germline transcription is to direct 
AID to specific S regions by making these regions suitable substrates for AID action (Stavnezer 
et al., 2008).  Transcription mediated mechanisms provide AID with substrate access since 
transcription through the S region creates R loops, RNA-DNA hybrid structures in which the 
newly synthesized RNA molecule remains associated with the C rich DNA template strand, 
leaving the non-template G rich strand of a single stranded nature for long stretches (Reaban and 
Griffin, 1990; Yu et al., 2003).  However, AID equally deaminates both the template and non-
template strand during CSR and SHM (Shen et al., 2006; Xue et al., 2006); therefore, the 
mechanism by which AID accesses the template DNA strand has been a major question in the 
field of AID biology (Chaudhuri et al., 2007; Di Noia and Neuberger, 2007; Liu and Schatz, 
2009; Maul and Gearhart, 2010; Pavri et al., 2010).  Here, we seek to uncover the mechanism by 
which transcription facilitates AID access to both the non-template as well as the template strand 
of substrate DNA.  
 AID has been shown to co-immunoprecipitate with RNA polymerase II (Nambu et al., 
2003). Additionally, recent studies have discovered a mechanism of AID recruitment to the S 
regions in the context of pausing of RNA polymerase.  In this mechanism, paused RNA 
polymerase II (RNAP II) cofactor Spt5 facilitates association between AID and RNAP II, as well 
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as mediates AID recruitment to Ig and non-Ig targets (Pavri et al., 2010).  Stalled RNAP II  is 
degraded via the Ubiquitin-Proteasome system (UPS) (Anindya et al., 2007). Using Chromatin 
Immunoprecipitation studies we find in the absence of Nedd4, the RNA polymerase Ubiquitin-
E3 ligase, S region levels of RNAP II increase. This result suggests Nedd4 facilitates removal of 
stalled RNAP II from the S regions. However, ChIP assays reveal only a snapshot of the total 
RNA PolII distribution at any given locus at a specific time (Nechaev and Adelman, 2011). In 
the future, nuclear run on assays can be performed to analyze transcriptional complexes in the S 
regions of Nedd4 knockdown or deficient cells to determine quantitative levels of polymerase 
pausing, backtracking, and restarting.  
  Another possibility for the equal targeting of AID to both the template and 
nontemplate strands arises from the occurrence of bidirectional transcription at the IgH variable 
regions (Perlot et al., 2008; Ronai et al., 2007).  In parallel, it has been discovered that RNAP II 
antisense transcripts are targeted for degradation by the RNA exosome (Flynn et al., 2011). 
Although the possibility exists that antisense IgS transcripts may provide AID access to the 
template strand of DNA, this will be in contrast to existing literature demonstrating that at least 
in IgSg3, ablation of antisense transcripts have minimum effect on CSR (Haddad et al., 2011). In 
contrast, sense germline transcripts are absolutely essential for CSR, indicating RNA access to 
these transcripts plays an important role in CSR. Additional experiments are necessary to 
examine directionality of transcription around germline promoters in these regions. Orientation 
specific q-PCR (Preker et al., 2008) can be utilized in CH12F3 wild-type, sh:Rrp40, and 
sh:Nedd4 cell lines.  These PCR reactions will allow us to examine the directionality and steady 
state level of  transcripts  produced  downstream  of  the  switch  region  promoters  (Sμ,  Sα)  following  
induction of CSR. 
115 
 
 It is also possible that transcription can alter histone modifications. Histone modifications 
can increase the accessibility of the DNA to transcription factors or the RNAP II machinery 
itself. Also, as AID-induced mutations in DNA lead to the formation of double strand breaks, it 
is possible that chromatin is remodeled concurrently as DSBs are formed.  Indeed, previous 
studies have found that transcription, B cell activation, and AID expression influence acetylation 
(Ac) of S region chromatin. This Ac, occurring on H3 and H4, may be important for DNA repair 
targeted to the S regions (Wang et al., 2006).  Genome-wide H3K4me3 profiling studies of 
murine B cells reveal a four-fold increase in H3K4me3 after LPS stimulation to undergo class 
switching, with increases detected in LPS inducible genes such as IL6, Igh switch regions, and 
Aicda (Daniel et al., 2010).  Accumulation of chromatin modifier MLL3/MLL4-complex 
component PTIP has been found at sites of DSBs in CSR.  Cells deficient in PTIP display 
defective CSR and genome instability, independent of Igh switch transcription (Daniel et al., 
2010), supporting the role of chromatin modifications in CSR.  
 Additionally, when RNAP II encounters a nucleosome, it has been shown to pause with a 
distinctive 10bp periodicity, and then backtrack by 10-15 base pairs. Backtracking of the RNA 
polymerase  can  reveal  a  free  3’  end  of  the  RNA (Adelman et al., 2005), providing a substrate for 
the RNA to degrade.  This backtracking mechanism and subsequent degradation of nascent RNA 
by the exosome complex is another possibility for template strand access by AID. Indeed, 
previous studies have found that RNAP II stalls during transcription of S regions (Rajagopal et 
al., 2009), and AID has been demonstrated to be associated with the paused RNAP II complex 
via association with pausing factor Spt5 (Pavri et al., 2010), providing feasibility to this 
hypothesis.  In the event that nuclear run on studies allow us to analyze RNA Pol II occupancy at 
the IgS regions, we will then utilize these data sets together with the data from RNA PolII ChIP 
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(Figures 3.10, 3.11), and compare this polymerase occupancy data with public data sets 
generated by the ENCODE project.  These data sets contain information of chromatin 
modifications and transcription factor binding sites genome-wide.  Overall, these analyses will 
potentially correlate our ChIP-experiment based studies with markers of active transcription, 
including acetylation on H3 and H4, as well as binding of factors such as PTIP and SPT5.  
 
4.2. Implications of AID/RNA Exosome Biochemistry 
 We have demonstrated functional relevance of the RNA exosome in the process of CSR 
by using shRNA knockdown cell lines, ChIP, and physical association studies.  However, these 
experiments provide limited mechanistic understanding. Our biochemical studies reveal the core 
exosome targets AID to both strands of T7 transcribed substrates in vitro. We note however, T7 
polymerase is both structurally and mechanistically distinct from mammalian RNA polymerase. 
Furthermore, in vitro systems do not operate in the same chromatin context as occurs in vivo 
during SHM and CSR.  Nevertheless, this biochemical assay was instrumental in identification 
of   exosome’s   role   in   CSR.   These   variations   from   the   in vivo system can be manipulated to 
identify the exact capabilities of the exosome or individual exosome subunits, making this an 
ideal system for exosome biochemistry analysis. 
 The evolutionarily conserved RNA exosome complex is required for degradation and/or 
processing of various RNA substrates. These substrates include noncoding RNAs generated as a 
result of error-prone transcription or from transcription initiated at cryptic promoters (Houseley 
et al., 2006; Jensen and Moore, 2005; Lykke-Andersen et al., 2009).  In bacteria, the exosome 
core subunits contain ribonuclease activity. In yeast and mammalian cells, the core subunits lack 
this activity, and therefore have been regarded to function only as structural scaffolds (Greimann 
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and Lima, 2008; Houseley et al., 2006; Jensen and Moore, 2005), and the enzymatic activity is 
provided by noncore subunits or other cofactors (Greimann and Lima, 2008; Houseley et al., 
2006; Tomecki et al., 2010).  Our biochemical data demonstrates that the core exosome, in the 
absence of catalytic subunits, targets AID to both strands of the T7 transcribed substrate.  
 Previous studies have shown that AID is targeted to the nontemplate strand of transcribed 
substrates by RPA, a single stranded DNA binding protein. RPA recognizes AID which has been  
phosphorylated on S38 by protein kinase A (PKA) (Basu et al., 2005; Chaudhuri et al., 2004), 
enhances AID deamination activity, and may also assist in recruitment of downstream repair 
pathways involved in processing of AID initiated lesions.  We have performed biochemical 
assays to examine exosome-mediated AID targeting in the context of both RPA presence or S38 
phosphorylation; we find that neither activity is required for exosome function.  Exosome 
function with regard to AID targeting appears to be a distinct and additive function from that of 
S38 phosphorylation and RPA binding. We have not examined neddylation events in the context 
of S38 phosphorylation and RPA binding. As the neddylation event always occurs on a lysine 
residue, we do not expect modification of S38 to affect neddylation activity. 
 
4.3. Implications of AID Neddylation 
 Our biochemical data unequivocally demonstrates targeting of AID to both strands of the 
T7 transcribed substrate is enhanced by the core exosome.  However, the molecular mechanism 
of core exosome mediated targeting is not elucidated by these studies.  In order to gain insight 
into the molecular mechanism of AID targeting, we continued to seek AID interacting proteins in 
the context of DNA binding.  These interacting proteins may either (1) facilitate exosome 
recruitment or (2) facilitate germline transcript RNA degradation, hence freeing the template 
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strand for AID access. Our search for AID interacting proteins revealed several enzymatic 
components of a post-translational small ubiquitin like modifier, Nedd8.  
  Neddylation has been shown to regulate several different cellular functions, including 
cell cycle control (Doronkin et al., 2003; Milhollen et al., 2011), regulation of ubiquitination 
(Oved et al., 2006), transcriptional regulation (Xirodimas et al., 2004), and the control of 
ribosomal stability (Xirodimas et al., 2008).  There have been few clearly defined substrates of 
neddylation (Rabut and Peter, 2008), and using these substrates as models we seek to define AID 
as a neddylation substrate.  Using primary splenocytes and cell lines, we find that AID is 
neddylated in B cells and exogenously expressed fibroblasts.  Using a combination of proteomic 
and computational screens, we find that the E3 ligase Nedd4 mediates AID neddylation on lysine 
residues K10 and/or K16, and loss of this neddylation event at these residues leads to defects in 
CSR.  In addition, we find that neddylation of AID stabilizes its interaction with the RNA 
exosome.  Mutation of AID neddylation residues results in a decrease in interaction with 
components of the RNA exosome and a decrease in CSR. 
 Together, these results demonstrate neddylation of AID as an important event in CSR.  
We envision that the neddylation event may serve one of three purposes (Rabut and Peter, 2008): 
(1) Induce conformational changes: We observe AID to be neddylated at residues K10 and K16, 
located within the nuclear localization sequence (NLS, positions 8-26 (Barreto and Magor, 
2011)).  It is possible that neddylation at these residues renders the NLS more active and 
localizes AID to the nucleus for an extended period of time.  To this end, we will analyze 
nuclear, cytoplasmic, and chromatin fractions of cellular protein extracts from 293T cells 
transiently transfected with AID or AIDK10AK16A , both with and without a Nedd8 expression 
plasmid. We will compare the amounts of AID protein and neddylated AID in each cellular 
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compartment when Nedd8 is present and when AID cannot be neddylated (AIDK10AK16A ). (2)  
Neddylation may preclude other interactions: Nuclear AID has previously been shown to be 
ubiquitinated leading to its degradation by the ubiquitin proteasome system (Aoufouchi et al., 
2008).  It is possible that neddylation and ubiquitin compete for access to the same lysine 
residue.  Neddylation could keep AID in the nucleus, where it accesses its DNA substrates, while 
ubiquitin leads to degradation. However, a specific lysine residue for ubiquitin modification has 
not been identified. Previous studies have mutated all lysines in the AID protein as well as 
creating a lysineless mutant, but without the successful identification of the site of ubiquitin 
modification (Aoufouchi et al., 2008), so we are not able to determine if neddylation and 
ubiquitin ligases utilize the same lysine residues.  However, we plan to perform in vitro 
competition assays in which ubiquitin and nedd8 are both added to the reaction as substrates to 
determine specificity of E3 enzymes for AID modification. (3) Provide a novel binding surface: 
Neddylation of AID can provide a binding site for interaction with the RNA exosome.  This 
hypothesis is concurrent with our findings of AID lysine mutants showing decreased interaction 
with RNA exosome components (Figure 3-9), as well as our findings showing a decreased 
interaction of exosome components and AID immunoprecipitated from neddylation enzyme 
deficient cells (Figure 3-7).  
 
4.4. Dual Functions of the Nedd4 E3 Ligase 
 Drawing on previous studies of E3 ubiquitin ligases which also function as E3 ligases for 
other small ubiquitin like molecules, including MDM2 (neddylation and ubiquitination E3 
ligase) and Topors (SUMO and ubiquitination E3 ligase), we conducted a computational screen 
for AID or AID homologues which interacted with known E3 ligases.  Our screen revealed 
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several possible E3 ligases, and upon further analysis, we obtained a candidate E3 ligase for AID 
neddylation as Nedd4. Nedd4 has been reported previously to be an E3 ligase for ubiquitination 
of RNA polymerase (Anindya et al., 2007). Biochemical studies using highly purified 
recombinant factors demonstrated that the predominant substrate for Nedd4 E3 ubiquitination is 
arrested RNA Pol II complexes (Somesh et al., 2005). In response to UV-induced DNA damage 
and transcriptional arrest in human cells, Nedd4 was demonstrated to be the E3 ubiquitin ligase 
which targets arrested RNA PolII complexes for degradation. Rather than serving directly as a 
damage response, this RNA PolII ubiquitination is thought to be a consequence of DNA lesions 
which block RNA PolII progression (Anindya et al., 2007). Using biochemical approaches, we 
determined that Nedd4 can also function as a neddylation ligase by neddylating AID.  
 As discussed, it is not uncommon to find E3 ligases which can function to ligate different 
modifiers onto the target protein(s). It is possible that one E3 ligase which can serve dual 
functions can benefit the organism.  For example, having several E3 ligases perform overlapping 
functions can be beneficial, because if one E3 is lost, another can compensate. This 
compensation occurs in the case of Topors, a dual SUMO/ubiquitin ligase important for genetic 
stability and tumor suppression.  When Topors is lost, total amounts of ubiquitin or SUMO 
conjugates in pMEFs are unaffected, suggesting compensation by other cellular ligases (Marshall 
et al., 2010). 
 The finding that Nedd4 can function as a ubiquitin E3 ligase (of the ubiquitin proteasome 
pathway) as well as a neddylation E3 ligase would be advantageous as the proteasome has been 
demonstrated to function at multiple steps of the transcription process and can function to 
regulate transcription of S regions. The proteasome participates in gene transcription through 
both proteolytic and nonproteolytic functions, including transcription factor processing, co-
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activator proteolysis, chromatin modifications, and control of elongation and termination 
(Konstantinova et al., 2008).   
 A functional proteasome is required for AU-Rich Element (ARE) mediated decay, an 
mRNA  degradation  process  mediated  in  the  3’-5’  direction  by  the  RNA  exosome  and  in  the  5’-3’  
direction by the Xrn1 exonuclease. For example, inhibition of the proteasome with inhibitor 
MG132 or inhibition of the E1 ubiquitin activating enzyme block decay of AU rich mRNAs 
(Laroia et al., 1999). Additionally, expression of a deubiquitinase which blocks addition of 
ubiquitin to substrate proteins completely blocked ARE-mediated decay. ARE-mediated turnover 
was found to be activated by the addition of ubiquitin to the substrate protein (Laroia et al., 
2002). Together, these experiments indicate dependence of the ARE mediated decay pathway on 
a functional ubiquitin proteasome degradation pathway.  The ubiquitin proteasome pathway is 
also required for additional mRNA surveillance pathways  which  utilize  the  3’-5’  exosome  (and  
5’-3’  Xrn1  exoribonuclease  pathway)  including  the  Nonsense  Mediated  Decay  Pathway  (NMD),  
Nonstop Decay (NSD), and No-Go Decay (NGD) pathways (Brooks, 2010).  
 The proteasome itself also been demonstrated to have RNAse activity.  This RNAse 
activity has been found to specifically localize to the zeta and iota subunits of the 20S subunit of 
the proteasome (Petit et al., 1997). Proteasome RNAse activity has been studied in K562 cells, a 
human immortalized erythroblastoid cell line isolated from a patient with chronic myelogenous 
lymphoma (Andersson et al., 1979). Treatment of K562 cells with apoptosis or differentiation 
inductors resulted in specific stimulation of proteasome RNAse activity towards some mRNA 
substrates and inhibition of activity towards other substrates (Mittenberg et al., 2007).  This 
result indicates the RNAse activity of the proteasome is regulated during cellular differentiation 
and apoptosis. As we have demonstrated the core exosome, without associated catalytic subunits, 
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is capable of mediating AID access to both strands of the DNA substrate, it is attractive to 
propose that the proteasome may associate with the exosome and provide the RNAse activity 
necessary to degrade the germline transcript.  Indeed, through co-localization 
immunocytochemistry, the proteasome has been demonstrated to associate with RNA exosome 
components (Brooks, 2010). However, these interactions were demonstrated for RNA exosome 
RNAse components Rrp44 and Rrp6, and further experiments are necessary to support this 
hypothesis, including demonstration of interaction with the core RNA exosome subunits which 
could be performed by binding studies using recombinant exosome subunits or chromatin 
immunoprecipation studies of endogenous exosome complexes.   
 Chromatin structure can also be altered by the proteasome, which is accomplished by the 
19S subunit. The ATPases of the 19S subunit, Rpt4 and Rpt6, are necessary for methylation of 
histone H3 at residues K4 and K79 (Ezhkova and Tansey, 2004).  Mutation of Rpt4 and Rpt6 
disrupts epigenetic gene regulation by disrupting methylation at these residues, as well as 
disrupting telomeric gene silencing, indicating a role for the 19S subunit in chromatin regulation 
(Ezhkova and Tansey, 2004). Additionally, proteolytic activities of the proteasome are involved 
in chromatin regulation as certain transcriptional activators have been shown to be targeted for 
degradation only after binding to their target promoter (Konstantinova et al., 2008).   
 These functions of the proteasome in transcriptional regulation are attractive strategies to 
explain how Nedd4 assists in AID template access. An example of Nedd4 in the role of 
transcription coupled DNA access has been demonstrated for the ubiquitin mediated proteasomal 
degradation of stalled RNA Pol II at sites of UV induced DNA damage (Anindya et al., 2007).  
Evidence of the role of chromatin modifications, including H3 and H4 histone acetylation (Wang 
et al., 2006) and the association of chromatin modification complexes during activation for CSR 
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(Daniel et al., 2010) has been demonstrated.  Further experiments are necessary to probe the role 
of the proteasome in modification of chromatin during CSR.   
  
4.5. Mechanistic Insights of AID substrate access 
 We propose a working model for how both the Nedd4 E3 ligase and the RNA exosome 
may enhance targeting of AID to both strands of the target DNA of in vivo substrates. This 
model is based on our current biochemical and cellular findings regarding relationships between 
AID, RNA exosome and neddylation enzymes, known aspects of AID function and recruitment 
to transcribed target sequences, and known RNA exosome and neddylation properties.  To 
enhance AID activity on the template strand, the RNA exosome must in some way remove the 
template RNA. The RNA exosome has not been shown to act on RNA substrates that lack a free 
3’end.  Therefore,  it  is  unlikely  that  the  exosome would act on the germline transcript while it is 
still hybridized to the template strand, and still attached to the stalled RNA Pol II complex.  We 
propose Nedd4 mediated ubiquitination can promote the degradation of stalled RNA polymerase 
II complexes located at the Ig-switch region. This degradation of RNA polymerase complexes 
can  generate  a  free  3’end  of  the  non-coding RNA transcript, would also remain hybridized to the 
template strand of the immunoglobulin switch sequence (Figure 4.1). Therefore, this 3’end  of  
the RNA transcript would serve two purposes (1) Target ssDNA deaminase AID to the 
RNA/DNA hybrid formed on the template strand, and (2) serve as a substrate for the RNA 
exosome, stimulating its accumulation on transcribed switch sequences in the Ig locus where the 
exosome can facilitate removal of the noncoding RNA.  Consistent with this model, we find the 




Figure 4-1: Model for AID substrate access, facilitated by 
Neddylation and RNA exosome complexes.  See above paragraph 











   
5. Concluding Remarks 
 Neddylation is a site specific event, but has been shown to compete with other 
modifications which occur at the same site, such as ubiquitination (Oved et al., 2006). AID has 
been shown to be ubiquitinated, leading to its degradation by the proteasome (Aoufouchi et al., 
2008). It is not clear of the specific residue for AID ubiquitination; therefore, we cannot rule out 
exclusive neddylation events at lysines 10 and 16, or a potential competition with ubiquitination. 
To address this question, we will perform competitive binding experiments to address the 
binding preference at a specific lysine residue as well as to address the binding preference of the 
E3 ligase for ubiquitin or Nedd8. Also, other mechanisms which we cannot discount, including 
backtracking of the stalled RNA polymerase, may contribute towards the generation of the free 
3’end  of  the  RNA  transcript.  Nuclear run on assays can be used to map regions of stalled RNA 
polymerase which will provide a quantitative analysis of transcriptionally engaged polymerases.  
RNA polymerase backtracking can be determined by analyzing the short RNA transcripts 
generated from stalled RNA PolII. These analyses can be performed by a global RNA 
sequencing method at high resolution, such as Global Run On Sequencing (GRO-Seq) 
techniques.  If successful, these analyses can reveal the position, amount, and orientation of 
transcriptionally engaged RNA Polymerases genome-wide (Core et al., 2008).   
 This work underscores the importance of identification of the mechanism of AID 
substrate selection. Overexpression of AID has been shown to lead to organ specific cancers in a 
transgenic mouse model; however, it is not known if the organ specificity is due to the 
transcription of the oncogene which targets AID or tumorigenic characteristics of the tumor cells 
itself (Morisawa et al., 2008). Genome-wide   sequencing   of   Peyer’s   patch  B   cells   reveals   that  
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AID can act on non-immunoglobulin targets (Liu et al., 2008). Mutational frequencies of 31 non-
immunoglobulin genes were found to be increased as a result of AID-induced somatic 
hypermutation. These studies suggest that certain parts of the genome are protected from 
aberrant mutation by mechanisms of high-fidelity DNA repair such as mismatch repair and base 
excision repair pathways. (Liu et al., 2008). Additionally, chromosome translocations that may 
result as an aberrant product of normal CSR mechanisms between the IgH switch region locus 
and c-myc oncogene   are   characteristic   of   the   human   B   cell   malignancy   Burkitt’s   lymphoma  
(Leder et al., 1983; Adams et al., 1982; Taub et al., 1982). It has been suggested that a loss of 
AID targeting mechanisms underlies abnormal somatic hypermutation, where genes undergo 
SHM within B cell tumors (Kuppers and Dalla-Favera, 2001; Liu et al., 2008; Pasqualucci et al., 
2001). As both aberrant CSR and SHM can contribute to mutagenesis of non-immunoglobulin 
genes, it is important to identify mechanisms of AID targeting and regulation.  
Results from both preclinical and early Phase I clinical trials indicate the potential of the 
Nedd8-activating enzyme inhibitor MLN4924 as a targeted therapeutic in the treatment of 
hematologic malignancies (Milhollen et al., 2010; Millennium Pharmaceuticals and Limited, 
2011). These hematologic malignancies have not been investigated for AID expression or AID-
induced chromosomal translocations.  Further studies can be performed, including analysis of 
AID mRNA and protein and chromosomal karyotype analysis, to evaluate the link between AID 
neddylation and hematologic malignancies.  Elucidating the mechanism of AID target selection 
in the context of transcriptional regulation will lead to progress in both general understanding of 
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